

 



<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
  "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml"
      xmlns:foaf="http://xmlns.com/foaf/0.1/"
      xmlns:dc="http://purl.org/dc/terms/"
      xmlns:doi="http://dx.doi.org/"
      xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
      xmlns:xsd="http://www.w3.org/2001/XMLSchema-datatypes#"
      lang="en" xml:lang="en"
      itemscope itemtype="http://schema.org/Article"
      class="no-js">
<head prefix="og: http://ogp.me/ns#">
  <title>PLOS ONE: Anti-Human Tissue Factor Antibody Ameliorated Intestinal Ischemia Reperfusion-Induced Acute Lung Injury in Human Tissue Factor Knock-In Mice</title>


<link rel="stylesheet" type="text/css"  href="/css/global-min.css?v=izteQ6tu7kgsJZW_xmrYizvKiHM" />


    <!--[if lte IE 7]>
<link rel="stylesheet" type="text/css"  href="/css/lte_ie7-min.css?v=3bykQUyQmReeuobVyPozcJ9LxRc" />
    <![endif]-->


<link rel="stylesheet" type="text/css"  href="/css/jquery-ui-min.css?v=eXDHTEJM0lIAmDe5k0I0Ad4nxNo" />


<link rel="stylesheet" type="text/css"  href="/css/journal.css?v=T7ZVxJfgk9jNxLAJ2qHz1vZpgYU" />


<link rel="stylesheet" type="text/css" media="print" href="/css/print-min.css?v=T5lb0B3q6EXBsuDluc5V5w+AkRc" />


  <link rel="stylesheet" href="http://f.fontdeck.com/s/css/js/www.plosone.org/24557.css" type="text/css"/>

  <!--chartbeat -->
  <script type="text/javascript">var _sf_startpt = (new Date()).getTime()</script>
  <script>document.documentElement.className += ' js';</script>

  <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
  <meta http-equiv="X-UA-Compatible" content="IE=EmulateIE7; IE=EmulateIE9"/>
  <meta name="description" content="PLOS ONE: an inclusive, peer-reviewed, open-access resource from the PUBLIC LIBRARY OF SCIENCE. Reports of well-performed scientific studies from all disciplines freely available to the whole world."/>
  <meta name="keywords" content="PLOS, Public Library of Science, Open Access, Open-Access, Science, Medicine, Biology, Research, Peer-review, Inclusive, Interdisciplinary, Ante-disciplinary, Physics, Chemistry, Engineering"/>
  <meta name="almHost" content="http://alm.plos.org/api/v3/articles"/>
  <meta name="searchHost" content="http://api.plos.org/search" />
  <meta name="termsHost" content="http://api.plos.org/terms" />
  <meta name="solrApiKey" content="plos"/>
  <meta name="almAPIKey" content="3pezRBRXdyzYW6ztfwft" />
  <meta name="currentJournal" content="PLoSONE" />
  <meta name="almRequestBatchSize" content="" />

  <meta name="citation_publisher" content="Public Library of Science"/>
  <meta name="citation_doi" content="10.1371/journal.pone.0001527"/>
  <meta name="dc.identifier" content="10.1371/journal.pone.0001527" />

    <meta name="citation_title" content="Anti-Human Tissue Factor Antibody Ameliorated Intestinal Ischemia Reperfusion-Induced Acute Lung Injury in Human Tissue Factor Knock-In Mice"/>
    <meta itemprop="name" content="Anti-Human Tissue Factor Antibody Ameliorated Intestinal Ischemia Reperfusion-Induced Acute Lung Injury in Human Tissue Factor Knock-In Mice"/>

      <meta name="citation_author" content="Xiaolin He"/>
            <meta name="citation_author_institution" content="Latner Thoracic Surgery Research Laboratories, Department of Surgery, University Health Network Toronto General Research Institute, University of Toronto, Toronto, Ontario, Canada"/>
      <meta name="citation_author" content="Bing Han"/>
            <meta name="citation_author_institution" content="Latner Thoracic Surgery Research Laboratories, Department of Surgery, University Health Network Toronto General Research Institute, University of Toronto, Toronto, Ontario, Canada"/>
      <meta name="citation_author" content="Marco Mura"/>
            <meta name="citation_author_institution" content="Latner Thoracic Surgery Research Laboratories, Department of Surgery, University Health Network Toronto General Research Institute, University of Toronto, Toronto, Ontario, Canada"/>
      <meta name="citation_author" content="Li Li"/>
            <meta name="citation_author_institution" content="Therakos, Exton, Pennsylvania, United State of America"/>
      <meta name="citation_author" content="Marcelo Cypel"/>
            <meta name="citation_author_institution" content="Latner Thoracic Surgery Research Laboratories, Department of Surgery, University Health Network Toronto General Research Institute, University of Toronto, Toronto, Ontario, Canada"/>
      <meta name="citation_author" content="Avery Soderman"/>
            <meta name="citation_author_institution" content="Centocor Inc., Malvern, Pennsylvania, United States of America"/>
      <meta name="citation_author" content="Kristen Picha"/>
            <meta name="citation_author_institution" content="Centocor Inc., Malvern, Pennsylvania, United States of America"/>
      <meta name="citation_author" content="Jing Yang"/>
            <meta name="citation_author_institution" content="Centocor Inc., Malvern, Pennsylvania, United States of America"/>
      <meta name="citation_author" content="Mingyao Liu"/>
            <meta name="citation_author_institution" content="Latner Thoracic Surgery Research Laboratories, Department of Surgery, University Health Network Toronto General Research Institute, University of Toronto, Toronto, Ontario, Canada"/>

    <meta name="citation_date" content="2008/1/30"/>

  <meta name="citation_pdf_url" content="http://dx.plos.org/10.1371/journal.pone.0001527.pdf" />

      <meta name="citation_journal_title" content="PLOS ONE" />
    <meta name="citation_firstpage" content="e1527"/>
    <meta name="citation_issue" content="1"/>
    <meta name="citation_volume" content="3"/>
    <meta name="citation_issn" content="1932-6203"/>

    <meta name="citation_journal_abbrev" content="PLoS ONE" />

      <meta name="citation_reference" content="citation_title=Searching for acute respiratory distress syndrome genes: aren't we there yet?; citation_author=M Liu; citation_journal_title=Am J Respir Crit Care Med; citation_volume=171; citation_number=1; citation_pages=298-299; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Local activation of the tissue factor-factor VIIa pathway in patients with pneumonia and the effect of inhibition of this pathway in murine pneumococcal pneumonia.; citation_author=AW Rijneveld; citation_author=S Weijer; citation_author=P Bresser; citation_author=S Florquin; citation_author=GP Vlasuk; citation_journal_title=Crit Care Med; citation_volume=34; citation_number=2; citation_pages=1725-1730; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Coagulation abnormalities in acute lung injury and sepsis.; citation_author=E Abraham; citation_journal_title=Am J Respir Cell Mol Biol; citation_volume=22; citation_number=3; citation_pages=401-404; citation_date=2000; " />
      <meta name="citation_reference" content="citation_title=Blockade of tissue factor: treatment for organ injury in established sepsis.; citation_author=MS Carraway; citation_author=KE Welty-Wolf; citation_author=DL Miller; citation_author=TL Ortel; citation_author=S Idell; citation_journal_title=Am J Respir Crit Care Med; citation_volume=167; citation_number=4; citation_pages=1200-1209; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=Local activation of coagulation and inhibition of fibrinolysis in the lung during ventilator associated pneumonia.; citation_author=MJ Schultz; citation_author=J Millo; citation_author=M Levi; citation_author=CE Hack; citation_author=GJ Weverling; citation_journal_title=Thorax; citation_volume=59; citation_number=5; citation_pages=130-135; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Mechanical Ventilation with Lower Tidal Volumes and Positive End-expiratory Pressure Prevents Alveolar Coagulation in Patients without Lung Injury.; citation_author=G Choi; citation_author=EK Wolthuis; citation_author=P Bresser; citation_author=M Levi; citation_author=T van der Poll; citation_journal_title=Anesthesiology; citation_volume=105; citation_number=6; citation_pages=689-695; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Mechanistic coupling of protease signaling and initiation of coagulation by tissue factor.; citation_author=M Riewald; citation_author=W Ruf; citation_journal_title=Proc Natl Acad Sci U S A; citation_volume=98; citation_number=7; citation_pages=7742-7747; citation_date=2001; " />
      <meta name="citation_reference" content="citation_title=Thrombin signalling and protease-activated receptors.; citation_author=SR Coughlin; citation_journal_title=Nature; citation_volume=407; citation_number=8; citation_pages=258-264; citation_date=2000; " />
      <meta name="citation_reference" content="citation_title=Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa.; citation_author=E Camerer; citation_author=W Huang; citation_author=SR Coughlin; citation_journal_title=Proc Natl Acad Sci U S A; citation_volume=97; citation_number=9; citation_pages=5255-5260; citation_date=2000; " />
      <meta name="citation_reference" content="citation_title=Bidirectional relation between inflammation and coagulation.; citation_author=M Levi; citation_author=T van der Poll; citation_author=HR Buller; citation_journal_title=Circulation; citation_volume=109; citation_number=10; citation_pages=2698-2704; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Bench to bedside: targeting coagulation and fibrinolysis in acute lung injury.; citation_author=LB Ware; citation_author=E Camerer; citation_author=K Welty-Wolf; citation_author=MJ Schultz; citation_author=MA Matthay; citation_journal_title=Am J Physiol Lung Cell Mol Physiol; citation_volume=291; citation_number=11; citation_pages=L307-311; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Pulmonary coagulopathy as a new target in therapeutic studies of acute lung injury or pneumonia–a review.; citation_author=MJ Schultz; citation_author=JJ Haitsma; citation_author=H Zhang; citation_author=AS Slutsky; citation_journal_title=Crit Care Med; citation_volume=34; citation_number=12; citation_pages=871-877; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Efficacy and safety of recombinant human activated protein C for severe sepsis.; citation_author=GR Bernard; citation_author=JL Vincent; citation_author=PF Laterre; citation_author=SP LaRosa; citation_author=JF Dhainaut; citation_journal_title=N Engl J Med; citation_volume=344; citation_number=13; citation_pages=699-709; citation_date=2001; " />
      <meta name="citation_reference" content="citation_title=Coagulation blockade prevents sepsis-induced respiratory and renal failure in baboons.; citation_author=KE Welty-Wolf; citation_author=MS Carraway; citation_author=DL Miller; citation_author=TL Ortel; citation_author=M Ezban; citation_journal_title=Am J Respir Crit Care Med; citation_volume=164; citation_number=14; citation_pages=1988-1996; citation_date=2001; " />
      <meta name="citation_reference" content="citation_title=Blockade of tissue factor-factor X binding attenuates sepsis-induced respiratory and renal failure.; citation_author=KE Welty-Wolf; citation_author=MS Carraway; citation_author=TL Ortel; citation_author=AJ Ghio; citation_author=S Idell; citation_journal_title=Am J Physiol Lung Cell Mol Physiol; citation_volume=290; citation_number=15; citation_pages=L21-31; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Expression of human tissue factor under the control of the mouse tissue factor promoter mediates normal hemostasis in knock-in mice.; citation_author=LA Snyder; citation_author=KA Rudnick; citation_author=R Tawadros; citation_author=A Volk; citation_author=SH Tam; citation_journal_title=J Thromb Haemost; citation_number=16; citation_date=2007; " />
      <meta name="citation_reference" content="citation_title=CNTO 859, a humanized anti-tissue factor monoclonal antibody, is a potent inhibitor of breast cancer metastasis and tumor growth in xenograft models.; citation_author=CV Ngo; citation_author=K Picha; citation_author=F McCabe; citation_author=H Millar; citation_author=R Tawadros; citation_journal_title=Int J Cancer; citation_volume=120; citation_number=17; citation_pages=1261-1267; citation_date=2007; " />
      <meta name="citation_reference" content="citation_title=Inhibition of tissue factor-mediated coagulation markedly attenuates stenosis after balloon-induced arterial injury in minipigs.; citation_author=L Oltrona; citation_author=CM Speidel; citation_author=D Recchia; citation_author=SA Wickline; citation_author=PR Eisenberg; citation_journal_title=Circulation; citation_volume=96; citation_number=18; citation_pages=646-652; citation_date=1997; " />
      <meta name="citation_reference" content="citation_title=Intestinal I/R-Induced Acute Lung Injury and Oncotic Cell Death in Multiple Organs.; citation_author=M Mura; citation_author=CF Andrade; citation_author=B Han; citation_author=R Seth; citation_author=Y Zhang; citation_journal_title=Shock; citation_volume=28; citation_number=19; citation_pages=227-238; citation_date=2007; " />
      <meta name="citation_reference" content="citation_title=The early responses of VEGF and its receptors during acute lung injury: implication of VEGF in alveolar epithelial cell survival.; citation_author=M Mura; citation_author=B Han; citation_author=CF Andrade; citation_author=R Seth; citation_author=D Hwang; citation_journal_title=Crit Care; citation_volume=10; citation_number=20; citation_pages=R130; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Angiotensin-Converting Enzyme Inhibitor Captopril Prevents Oleic Acid-Induced Severe Acute Lung Injury in Rats.; citation_author=X He; citation_author=B Han; citation_author=M Mura; citation_author=S Xia; citation_author=S Wang; citation_journal_title=Shock; citation_volume=28; citation_number=21; citation_pages=106-111; citation_date=2007; " />
      <meta name="citation_reference" content="citation_title=Repeated pulmonary thromboembolism in rabbits.; citation_author=EG Olsen; citation_journal_title=Lab Invest; citation_volume=32; citation_number=22; citation_pages=323-329; citation_date=1975; " />
      <meta name="citation_reference" content="citation_title=Cell death in human lung transplantation: apoptosis induction in human lungs during ischemia and after transplantation.; citation_author=S Fischer; citation_author=SD Cassivi; citation_author=AM Xavier; citation_author=JA Cardella; citation_author=E Cutz; citation_journal_title=Ann Surg; citation_volume=231; citation_number=23; citation_pages=424-431; citation_date=2000; " />
      <meta name="citation_reference" content="citation_title=Caspase inhibition improves ischemia-reperfusion injury after lung transplantation.; citation_author=SM Quadri; citation_author=L Segall; citation_author=M de Perrot; citation_author=B Han; citation_author=V Edwards; citation_journal_title=Am J Transplant; citation_volume=5; citation_number=24; citation_pages=292-299; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=XB130, a novel adaptor protein for signal transduction.; citation_author=J Xu; citation_author=XH Bai; citation_author=M Lodyga; citation_author=B Han; citation_author=H Xiao; citation_journal_title=J Biol Chem; citation_volume=282; citation_number=25; citation_pages=16401-16412; citation_date=2007; " />
      <meta name="citation_reference" content="citation_title=Lipopolysaccharide accelerates caspase-independent but cathepsin B-dependent death of human lung epithelial cells.; citation_author=PS Tang; citation_author=ME Tsang; citation_author=M Lodyga; citation_author=XH Bai; citation_author=A Miller; citation_journal_title=J Cell Physiol; citation_volume=209; citation_number=26; citation_pages=457-467; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Linkage analysis of susceptibility to hyperoxia. Nrf2 is a candidate gene.; citation_author=HY Cho; citation_author=AE Jedlicka; citation_author=SP Reddy; citation_author=LY Zhang; citation_author=TW Kensler; citation_journal_title=Am J Respir Cell Mol Biol; citation_volume=26; citation_number=27; citation_pages=42-51; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=Vascular endothelial growth factor and related molecules in acute lung injury.; citation_author=M Mura; citation_author=CC dos Santos; citation_author=D Stewart; citation_author=M Liu; citation_journal_title=J Appl Physiol; citation_volume=97; citation_number=28; citation_pages=1605-1617; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Src protein tyrosine kinase family and acute inflammatory responses.; citation_author=D Okutani; citation_author=M Lodyga; citation_author=B Han; citation_author=M Liu; citation_journal_title=Am J Physiol Lung Cell Mol Physiol; citation_volume=291; citation_number=29; citation_pages=L129-141; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Expression of von Willebrand factor by human pulmonary endothelial cells in vivo.; citation_author=AM Muller; citation_author=C Skrzynski; citation_author=G Skipka; citation_author=KM Muller; citation_journal_title=Respiration; citation_volume=69; citation_number=30; citation_pages=526-533; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues.; citation_author=MP Pusztaszeri; citation_author=W Seelentag; citation_author=FT Bosman; citation_journal_title=J Histochem Cytochem; citation_volume=54; citation_number=31; citation_pages=385-395; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=The coagulation cascade: initiation, maintenance, and regulation.; citation_author=EW Davie; citation_author=K Fujikawa; citation_author=W Kisiel; citation_journal_title=Biochemistry; citation_volume=30; citation_number=32; citation_pages=10363-10370; citation_date=1991; " />
      <meta name="citation_reference" content="citation_title=Tissue factor modulation of factor VIIa activity: use in measuring trace levels of factor VIIa in plasma.; citation_author=JH Morrissey; citation_journal_title=Thromb Haemost; citation_volume=74; citation_number=33; citation_pages=185-188; citation_date=1995; " />
      <meta name="citation_reference" content="citation_title=Tissue factor expression during human and mouse development.; citation_author=T Luther; citation_author=C Flossel; citation_author=N Mackman; citation_author=A Bierhaus; citation_author=M Kasper; citation_journal_title=Am J Pathol; citation_volume=149; citation_number=34; citation_pages=101-113; citation_date=1996; " />
      <meta name="citation_reference" content="citation_title=Characterization of recombinant murine factor VIIa and recombinant murine tissue factor: a human-murine species compatibility study.; citation_author=LC Petersen; citation_author=PL Norby; citation_author=S Branner; citation_author=BB Sorensen; citation_author=T Elm; citation_journal_title=Thromb Res; citation_volume=116; citation_number=35; citation_pages=75-85; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Activation of factor X by factor VIIa complexed with human-mouse tissue factor chimeras requires human exon 3.; citation_author=CH Fang; citation_author=TC Lin; citation_author=A Guha; citation_author=Y Nemerson; citation_author=WH Konigsberg; citation_journal_title=Thromb Haemost; citation_volume=76; citation_number=36; citation_pages=361-368; citation_date=1996; " />
      <meta name="citation_reference" content="citation_title=Role of tissue factor and protease-activated receptors in a mouse model of endotoxemia.; citation_author=R Pawlinski; citation_author=B Pedersen; citation_author=G Schabbauer; citation_author=M Tencati; citation_author=T Holscher; citation_journal_title=Blood; citation_volume=103; citation_number=37; citation_pages=1342-1347; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Regulation of chemotaxis by the cytoplasmic domain of tissue factor.; citation_author=A Siegbahn; citation_author=M Johnell; citation_author=BB Sorensen; citation_author=LC Petersen; citation_author=CH Heldin; citation_journal_title=Thromb Haemost; citation_volume=93; citation_number=38; citation_pages=27-34; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=The acute respiratory distress syndrome.; citation_author=LB Ware; citation_author=MA Matthay; citation_journal_title=N Engl J Med; citation_volume=342; citation_number=39; citation_pages=1334-1349; citation_date=2000; " />
      <meta name="citation_reference" content="citation_title=The alveolar epithelium can initiate the extrinsic coagulation cascade through expression of tissue factor.; citation_author=JA Bastarache; citation_author=L Wang; citation_author=T Geiser; citation_author=Z Wang; citation_author=KH Albertine; citation_journal_title=Thorax; citation_volume=62; citation_number=40; citation_pages=608-616; citation_date=2007; " />

  <link rel="canonical" href="http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0001527" />

    <meta name="twitter:card" content="summary"/>
    <meta name="twitter:site" content="@plosone"/>
    <meta name="twitter:title" content="Anti-Human Tissue Factor Antibody Ameliorated Intestinal Ischemia Reperfusion-Induced Acute Lung Injury in Human Tissue Factor Knock-In Mice"/>
    <meta name="twitter:description" content="BackgroundInteraction between the coagulation and inflammation systems plays an important role in the development of acute respiratory distress syndrome (ARDS). Anti-coagulation is an attractive option for ARDS treatment, and this has promoted development of new antibodies. However, preclinical trials for these antibodies are often limited by the high cost and availability of non-human primates. In the present study, we developed a novel alternative method to test the role of a humanized anti-tissue factor mAb in acute lung injury with transgenic mice.Methodology/Principal FindingsHuman tissue factor knock-in (hTF-KI) transgenic mice and a novel humanized anti-human tissue factor mAb (anti-hTF mAb, CNTO859) were developed. The hTF-KI mice showed a normal and functional expression of hTF. The anti-hTF mAb specifically blocked the pro-coagulation activity of brain extracts from the hTF-KI mice and human, but not from wild type mice. An extrapulmonary ARDS model was used by intestinal ischemia-reperfusion. Significant lung tissue damage in hTF-KI mice was observed after 2 h reperfusion. Administration of CNTO859 (5 mg/kg, i.v.) attenuated the severity of lung tissue injury, decreased the total cell counts and protein concentration in bronchoalveolar lavage fluid, and reduced Evans blue leakage. In addition, the treatment significantly reduced alveolar fibrin deposition, and decreased tissue factor and plasminogen activator inhibitor-1 activity in the serum. This treatment also down-regulated cytokine expression and reduced cell death in the lung.ConclusionsThis novel anti-hTF antibody showed beneficial effects on intestinal ischemia-reperfusion induced acute lung injury, which merits further investigation for clinical usage. In addition, the use of knock-in transgenic mice to test the efficacy of antibodies against human-specific proteins is a novel strategy for preclinical studies."/>
      <meta name="twitter:image" content="http://dx.plos.org/10.1371/journal.pone.0001527.g005"/>

  <meta property="og:title" content="Anti-Human Tissue Factor Antibody Ameliorated Intestinal Ischemia Reperfusion-Induced Acute Lung Injury in Human Tissue Factor Knock-In Mice" />
  <meta property="og:type" content="article" />
  <meta property="og:url" content="http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0001527" />

 <!--end articleInfoX-->

  <link rel="pingback" href="http://www.plosone.org/pingback" />


  <link rel="shortcut icon" href="/images/favicon.ico" type="image/x-icon"/>
  <link rel="home" title="home" href="/"/>
  <link rel="alternate" type="application/rss+xml"
        title="PLOS ONE: New Articles"
        href="http://www.plosone.org/article/feed"/>
</head>
<body>

  <div id="page-wrap">
    <div id="topbanner" class="cf">

<!-- Div for the ad at the top of journal home page-->
<div class="center">
  <div class="title">Advertisement</div>
  <iframe id='a3ac9da4' name='a3ac9da4'
    src='http://ads.plos.org/www/delivery/afr.php?zoneid=345&amp;cb=2237'
    frameborder='0' scrolling='no' width='730' height='90'>
    <a href='http://ads.plos.org/www/delivery/ck.php?n=a3ac9da4&amp;cb=9280'
      target='_top'><img src='http://ads.plos.org/www/delivery/avw.php?zoneid=345&amp;cb=6504&amp;n=a3ac9da4'
      border='0' alt=''/>
    </a>
  </iframe>
</div>    </div>

    <div id="pagehdr-wrap">
      <div id="pagehdr">
        <div id="user" class="nav">
          <ul>
            <li><a href="http://www.plos.org">plos.org</a></li>
            <li><a href="https://register.plos.org/ambra-registration/register.action">create account</a></li>
            <li class="btn-style"><a
              href="/user/secure/secureRedirect.action?goTo=%2Farticle%2FfetchArticle.action%3FarticleURI%3Dinfo%253Adoi%252F10.1371%252Fjournal.pone.0001527">sign in</a>
            </li>
          </ul>
        </div>
        <div class="logo">
          <a href="/"><img src="/images/logo.png" alt="PLOS ONE"></a>
        </div>

<div id="nav-main" class="nav">
  <ul>
        <li id="mn-01"><a href="/taxonomy" class="areas-link">Subject Areas</a></li>
    <li id="mn-02"><a href="javascript:void(0);">For Authors</a>
      <div class="submenu" style="width: 540px; margin-left: -300px;">
        <div class="block">
          <div class="submit-script">
            <h3>Submit your Manuscript</h3>
            <ul>
              <li>Fair, rigorous peer review</li>
              <li>Broad scope and wide reach</li>
            </ul>
            <a href="/static/submissionInstructions" class="btn">get started</a>
          </div>
        </div>
        <div class="menu">
          <ul>
            <li><a href="/static/publish">Why Publish with PLOS ONE</a></li>
            <li><a href="/static/publication">Publication Criteria</a></li>
            <li><a href="/static/editorial">Editorial Policies</a></li>
            <li><a href="/static/guidelines">Preparing A Manuscript</a></li>
            <li><a href="/static/figureGuidelines">Figure and Table Guidelines</a></li>
          <li><a href="/static/supportingInformation">Supporting Information Guidelines</a></li>
            <li><a href="/static/submissionInstructions">Submitting a Manuscript</a></li>
          </ul>
        </div>
      </div>
    </li>

    <li id="mn-03"><a href="javascript:void(0);">About Us</a>
      <div class="submenu" style="width:248px; margin-left:-30px;">
        <div class="menu">
          <ul>
            <li><a href="/static/information">Journal Information</a></li>
            <li><a href="/static/edboard">Editorial Board</a></li>
            <li><a href="/static/reviewerGuidelines">Reviewer Guidelines</a></li>
            <li><a href="/static/almInfo">Article-Level Metrics</a></li>
            <li><a href="/static/license">Open-Access License</a></li>
            <li><a href="/static/downloads">Media Downloads</a></li>
            <li><a href="/static/commentGuidelines">Guidelines for Comments</a></li>
            <li><a href="/static/corrections">Corrections</a></li>
            <li><a href="/static/help">Help Using this Site</a></li>
            <li><a href="/static/contact">Contact Us</a></li>
          </ul>
        </div>
      </div>
    </li>
  </ul>
<div id="db">
  <form name="searchForm" action="/search/simple?noSearchFlag=true&amp;query=&amp;articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0001527" method="get" >
<input type="hidden" name="from" value="globalSimpleSearch" id="from"/><input type="hidden" name="filterJournals" value="PLoSONE" id="filterJournals"/>    <fieldset>
      <legend>Search</legend>
      <label for="search">Search</label>
      <div class="wrap">
        <input id="search" type="text" name="query" placeholder="Search">
        <input type="image" alt="SEARCH" src="/images/icon.search.gif">
      </div>
    </fieldset>
  </form>
    <a id="advSearch" href="/search/advanced?noSearchFlag=true&amp;query=&amp;articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0001527&filterJournals=PLoSONE">advanced search</a>
</div></div>

      </div>
      <!-- pagehdr-->
    </div>
    <!-- pagehdr-wrap -->

  <!--body and html tags gets closed in global_footer.ftl-->
<script type="text/javascript" src="/javascript/mathjax/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>

<div id="pagebdy-wrap">
  <div id="pagebdy">

    <div id="article-block" class="cf">

<div class="article-meta cf">
  <ul id="almSignPost" style="display: none;"></ul>
  <div class="article-type">
    <span class="type oa">Open Access</span>
      <span class="type pr">Peer-Reviewed</span>
  </div>
</div>

<div class="header" id="hdr-article">

<div class="article-kicker">
      <span id="article-type-heading">
        Research Article
      </span>
</div>  <h1 property="dc:title" datatype="" rel="dc:type" href="http://purl.org/dc/dcmitype/Text">
    Anti-Human Tissue Factor Antibody Ameliorated Intestinal Ischemia Reperfusion-Induced Acute Lung Injury in Human Tissue Factor Knock-In Mice
  </h1>

  <ul class="authors">
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Xiaolin He
              <span class="equal-contrib"
                    title="These authors contributed equally to this work">equal contributor</span>, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">

                <p><span class="equal-contrib" title="These authors contributed equally to this work">equal contributor</span>
                Contributed equally to this work with: Xiaolin He, Bing Han</p>

              
              

                <p>Affiliation:
                  Latner Thoracic Surgery Research Laboratories, Department of Surgery, University Health Network Toronto General Research Institute, University of Toronto, Toronto, Ontario, Canada
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Bing Han
              <span class="equal-contrib"
                    title="These authors contributed equally to this work">equal contributor</span>, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">

                <p><span class="equal-contrib" title="These authors contributed equally to this work">equal contributor</span>
                Contributed equally to this work with: Xiaolin He, Bing Han</p>

              
              

                <p>Affiliation:
                  Latner Thoracic Surgery Research Laboratories, Department of Surgery, University Health Network Toronto General Research Institute, University of Toronto, Toronto, Ontario, Canada
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Marco Mura, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Latner Thoracic Surgery Research Laboratories, Department of Surgery, University Health Network Toronto General Research Institute, University of Toronto, Toronto, Ontario, Canada
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Li Li, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Therakos, Exton, Pennsylvania, United State of America
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Marcelo Cypel, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Latner Thoracic Surgery Research Laboratories, Department of Surgery, University Health Network Toronto General Research Institute, University of Toronto, Toronto, Ontario, Canada
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Avery Soderman, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Centocor Inc., Malvern, Pennsylvania, United States of America
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Kristen Picha, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Centocor Inc., Malvern, Pennsylvania, United States of America
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Jing Yang, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Centocor Inc., Malvern, Pennsylvania, United States of America
                </p>

                <p>
                    Current address: Brystol-Myers Squibb Company, Pennington, New Jersey, United States of America
                </p>

              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Mingyao Liu
              <span class="corresponding">mail</span>
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              <p><span class="email">*</span>To whom correspondence should be addressed. E-mail: <a href="mailto:mingyao.liu@utoronto.ca">mingyao.liu@utoronto.ca</a></p>

                <p>Affiliation:
                  Latner Thoracic Surgery Research Laboratories, Department of Surgery, University Health Network Toronto General Research Institute, University of Toronto, Toronto, Ontario, Canada
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
  </ul>
  <ul class="date-doi-line">
    <li>Published: January 30, 2008</li>
    <li>DOI: 10.1371/journal.pone.0001527</li>
  </ul>


</div><!--end header-->
<div class="main cf" id="pjax-container">
  

<div class="nav items-5" id="nav-article">
  <ul>
  <li>
        <span class="active" name="article">Article</span>
  </li>
  <li>
      <a href="/article/authors/info%3Adoi%2F10.1371%2Fjournal.pone.0001527" name="authors">About the Authors</a>
  </li>
  <li>
      <a href="/article/metrics/info%3Adoi%2F10.1371%2Fjournal.pone.0001527" name="metrics">Metrics</a>
  </li>
  <li>
      <a href="/article/comments/info%3Adoi%2F10.1371%2Fjournal.pone.0001527" name="comments">Comments</a>
  </li>
  <li>
      <a href="/article/related/info%3Adoi%2F10.1371%2Fjournal.pone.0001527" name="related">Related Content</a>
  </li>
  </ul>
</div>

<script type="text/javascript">
  var selected_tab = "article";
</script>
  <div id="figure-thmbs" class="carousel cf">
    <div class="wrapper">
      <div class="slider">
              <div class="item">
                <a href="#pone-0001527-g001" data-doi="info:doi/10.1371/journal.pone.0001527" data-uri="info:doi/10.1371/journal.pone.0001527.g001" title="Figure 1">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001527.g001&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001527-g002" data-doi="info:doi/10.1371/journal.pone.0001527" data-uri="info:doi/10.1371/journal.pone.0001527.g002" title="Figure 2">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001527.g002&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001527-g003" data-doi="info:doi/10.1371/journal.pone.0001527" data-uri="info:doi/10.1371/journal.pone.0001527.g003" title="Figure 3">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001527.g003&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001527-g004" data-doi="info:doi/10.1371/journal.pone.0001527" data-uri="info:doi/10.1371/journal.pone.0001527.g004" title="Figure 4">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001527.g004&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001527-g005" data-doi="info:doi/10.1371/journal.pone.0001527" data-uri="info:doi/10.1371/journal.pone.0001527.g005" title="Figure 5">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001527.g005&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
      </div>
    </div>
  </div>

  <div class="nav-col">
    <div class="nav" id="nav-article-page">
      <ul>
        <li class="nav-col-comments"><a href="/article/comments/info%3Adoi%2F10.1371%2Fjournal.pone.0001527">Reader Comments (0)</a></li>
          <li id="nav-figures"><a data-doi="info:doi/10.1371/journal.pone.0001527" >Figures</a></li>
      </ul>
    </div>
  </div>

  <div class="article">







<div class="abstract"><a id="abstract0" name="abstract0" toc="abstract0" title="Abstract"></a><h2>Abstract</h2>
<h3>Background</h3>
<a id="article1.front1.article-meta1.abstract1.sec1.p1" name="article1.front1.article-meta1.abstract1.sec1.p1"></a><p>Interaction between the coagulation and inflammation systems plays an important role in the development of acute respiratory distress syndrome (ARDS). Anti-coagulation is an attractive option for ARDS treatment, and this has promoted development of new antibodies. However, preclinical trials for these antibodies are often limited by the high cost and availability of non-human primates. In the present study, we developed a novel alternative method to test the role of a humanized anti-tissue factor mAb in acute lung injury with transgenic mice.</p>


<h3>Methodology/Principal Findings</h3>
<a id="article1.front1.article-meta1.abstract1.sec2.p1" name="article1.front1.article-meta1.abstract1.sec2.p1"></a><p>Human tissue factor knock-in (hTF-KI) transgenic mice and a novel humanized anti-human tissue factor mAb (anti-hTF mAb, CNTO859) were developed. The hTF-KI mice showed a normal and functional expression of hTF. The anti-hTF mAb specifically blocked the pro-coagulation activity of brain extracts from the hTF-KI mice and human, but not from wild type mice. An extrapulmonary ARDS model was used by intestinal ischemia-reperfusion. Significant lung tissue damage in hTF-KI mice was observed after 2 h reperfusion. Administration of CNTO859 (5 mg/kg, i.v.) attenuated the severity of lung tissue injury, decreased the total cell counts and protein concentration in bronchoalveolar lavage fluid, and reduced Evans blue leakage. In addition, the treatment significantly reduced alveolar fibrin deposition, and decreased tissue factor and plasminogen activator inhibitor-1 activity in the serum. This treatment also down-regulated cytokine expression and reduced cell death in the lung.</p>


<h3>Conclusions</h3>
<a id="article1.front1.article-meta1.abstract1.sec3.p1" name="article1.front1.article-meta1.abstract1.sec3.p1"></a><p>This novel anti-hTF antibody showed beneficial effects on intestinal ischemia-reperfusion induced acute lung injury, which merits further investigation for clinical usage. In addition, the use of knock-in transgenic mice to test the efficacy of antibodies against human-specific proteins is a novel strategy for preclinical studies.</p>

</div>


<div class="articleinfo"><p><strong>Citation: </strong>He X, Han B, Mura M, Li L, Cypel M, et al.  (2008) Anti-Human Tissue Factor Antibody Ameliorated Intestinal Ischemia Reperfusion-Induced Acute Lung Injury in Human Tissue Factor Knock-In Mice. PLoS ONE 3(1):
          e1527.
            doi:10.1371/journal.pone.0001527</p><p><strong>Academic Editor: </strong>Jeffrey Gold, Oregon Health &amp; Science University, United States of America</p><p><strong>Received:</strong> November 6, 2007; <strong>Accepted:</strong> December 27, 2007; <strong>Published:</strong> January 30, 2008</p><p><strong>Copyright:</strong> © 2008 He et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p><p><strong>Funding: </strong>This work was funded by Canadian Institutes of Health Research Grants MOP-13270 and MOP-42546.</p><p><strong>Competing interests:</strong> The authors have declared that no competing interests exist.</p></div>





<div id="section1" class="section"><a id="s1" name="s1" toc="s1" title="Introduction"></a><h3>Introduction</h3><a id="article1.body1.sec1.p1" name="article1.body1.sec1.p1"></a><p>One of the important features and major underlying mechanisms of acute lung injury (ALI) and its severe form acute respiratory distress syndrome (ARDS) is the intensive inflammatory response <a href="#pone.0001527-Liu1">[1]</a>. Evidence from animals and human studies indicates that alveolar and interstitial coagulation disorder and fibrin deposition are the hallmarks of early phase ALI/ARDS and other inflammatory situations in the lung, including pneumonia <a href="#pone.0001527-Rijneveld1">[2]</a>, sepsis <a href="#pone.0001527-Abraham1">[3]</a>, <a href="#pone.0001527-Carraway1">[4]</a>, and ventilator-induced lung injury <a href="#pone.0001527-Schultz1">[5]</a>, <a href="#pone.0001527-Choi1">[6]</a>. Coagulopathy not only adds another pathological feature to ALI/ARDS, but also leads to inflammatory signals through the activation of protease-activated receptors (PARs) <a href="#pone.0001527-Riewald1">[7]</a>, <a href="#pone.0001527-Coughlin1">[8]</a>, <a href="#pone.0001527-Camerer1">[9]</a>, indicating an extensive cross-talk and reciprocal amplification between coagulation and inflammatory cascades <a href="#pone.0001527-Levi1">[10]</a>.</p>
<a id="article1.body1.sec1.p2" name="article1.body1.sec1.p2"></a><p>Recently, increased attention has been paid in both experimental and clinical research of ALI/ARDS to the interplay between coagulation and inflammation <a href="#pone.0001527-Ware1">[11]</a>, <a href="#pone.0001527-Schultz2">[12]</a>. Anticoagulant therapies were developed and tested in animals and humans. An infusion of activated protein C showed a beneficial effect on the mortality in patients with severe sepsis <a href="#pone.0001527-Bernard1">[13]</a>, supporting the role of an anti-coagulant therapy to treat inflammation. Since tissue factor (TF) is a key initiator of the coagulation cascade and plays a critical role in inflammation as well, anti-TF therapy is another attractive anticoagulant strategy. Several reagents against the TF complex at sequential steps in its assembly, including a competitive inhibitor of Factor VIIa and an antibody to the Factor X binding site on TF, were tested in an <em>E. coli</em> sepsis model in baboons <a href="#pone.0001527-Carraway1">[4]</a>, <a href="#pone.0001527-WeltyWolf1">[14]</a>, <a href="#pone.0001527-WeltyWolf2">[15]</a>. TF blockade has shown protective effects when administered at the onset of sepsis and given as a rescue therapy, decreasing systemic inflammation, preventing fibrinogen depletion, and attenuating injury to the lung, kidney, and other organs <a href="#pone.0001527-Carraway1">[4]</a>, <a href="#pone.0001527-WeltyWolf1">[14]</a>, <a href="#pone.0001527-WeltyWolf2">[15]</a>. These promising results support further development of new molecules targeting coagulation pathways for clinical applications.</p>
<a id="article1.body1.sec1.p3" name="article1.body1.sec1.p3"></a><p>Currently, non-human primates are generally the best pre-clinical models to test efficacy of antibodies against human proteins. However, these models are often limited by their high cost and animal availability. In the present study, we tested a humanized anti-hTF monoclonal antibody (CNTO859) in a clinically relevant ALI model induced by intestinal ischemia-reperfusion (IIR). However instead of using non-human primates, we developed human TF knock-in (hTF-KI) transgenic mice, which express human TF instead of murine TF (mTF). CNTO859 treatment significantly reduced IIR-induced lung injury, attenuated alveolar fibrin deposition and inflammatory responses in the lung. This novel antibody and the transgenic approach against human genes to conduct pre-clinical studies in mice merit further investigations.</p>
</div>

<div id="section2" class="section"><a id="s2" name="s2" toc="s2" title="Methods"></a><h3>Methods</h3>
<h4>hTF-KI transgenic mice and anti-hTF monoclonal antibody, CNTO859</h4>
<a id="article1.body1.sec2.sec1.p1" name="article1.body1.sec2.sec1.p1"></a><p>Generation of hTF-KI transgenic mice has been previously described <a href="#pone.0001527-Snyder1">[16]</a>. Briefly, the first two exons of murine TF gene was replaced in-frame by human TF cDNA. As a result, expression of mTF was completely disrupted and hTF was expressed under the control of mTF promoter. Chimeric mice derived from targeted 129SvBrd embryonic stem cells were bred with C57BL/6 mice to produce hTF/mTF heterozygous mice and the breeding colony was established by further backcrossing with C57BL/6 mice. hTFKI homozygous mice (hTF/hTF) and wild type littermates used in this study were derived from breeding N2 heterozygous mice.</p>
<a id="article1.body1.sec2.sec1.p2" name="article1.body1.sec2.sec1.p2"></a><p>The anti-hTF monoclonal antibody, CNTO859, was genetically engineered by grafting the complementarity–determining regions of a murine anti-hTF antibody, TF8-5G9, onto a human immunoglobulin G4 frame. The antibody consists of 5–10% murine and 90–95% human proteins <a href="#pone.0001527-Ngo1">[17]</a>.</p>


<h4>Testing of hTF activity in transgenic mice</h4>
<a id="article1.body1.sec2.sec2.p1" name="article1.body1.sec2.sec2.p1"></a><p>Pro-coagulant activity of hTF expressed in the transgenic mice was tested using a one-stage clotting assay with brain homogenate in comparison with that in wild type mice and in human brain tissue (ILSbio, Chestertown, MD). Approximately 25 mg brain tissues were homogenized in Hanks Balanced Salt Solution using Fast-prep protein isolator tubes (Bio 101 Systems, Qbiogene, Carlsbad, CA). Brain homogenates were frozen at −80°C immediately after isolation, and were diluted 1:100 prior to use. The total protein was measured at OD<sub>280 </sub>to determine concentration. Citrated human plasma (100 µl) was incubated with increasing concentrations of brain homogenate (200 µl and 10 mM CaCl<sub>2</sub>) and the clotting time was recorded using Organon Teknika Coag-A-mate XM <a href="#pone.0001527-Oltrona1">[18]</a>. All samples were tested in duplicate. The data were fit to a hyperbolic curve to determine an EC<sub>50</sub> (0.1 mg/ml for human and hTF-KI mouse brain extracts, 0.4 mg/ml for wild type littermate mouse extract).</p>
<a id="article1.body1.sec2.sec2.p2" name="article1.body1.sec2.sec2.p2"></a><p>We also used this assay to determine the inhibition efficacy and specificity of CNTO859 on human TF activity by incubating the brain extracts with increasing concentrations of either the CNTO859 or an anti-murine TF mAb. The changes of clotting time were recorded for comparison.</p>


<h4>Intestinal ischemia reperfusion-induced acute lung injury</h4>
<a id="article1.body1.sec2.sec3.p1" name="article1.body1.sec2.sec3.p1"></a><p>Acute lung injury was induced by intestinal ischemia-reperfusion as previously described <a href="#pone.0001527-Mura1">[19]</a>, <a href="#pone.0001527-Mura2">[20]</a> with modification. Briefly, male hTF-KI mice (6–8 weeks, 25–30 g) were anesthetized with 5% isoflurane. A tracheostomy cannula for mouse (H. Sachs Elektronik, March-Hugstetten, Germany) was inserted into the trachea, and animals were ventilated with a volume control ventilator (Inspira Advanced Safety Ventilator, Harvard Apparatus, St. Laurent, Canada) at a tidal volume of 6 ml/kg, inspiratory/expiratory ratio 1:2 and a frequency of 140 breaths/min (FiO<sub>2</sub> 100%). Anesthesia was maintained with 1.5% isoflurane and body temperature was maintained at 37°C throughout the experiment. A midline laparatomy was performed and the superior mesenteric artery was identified and occluded below the celiac trunk with an arterial micro-clamp (Mizuho Ikakogyo, Tokyo, Japan). Intestinal ischemia was confirmed by paleness of the jejunum and ileum. After 45 min of ischemia period, reperfusion was initiated by removal of the clamp and confirmed by the color recovery of the intestine. Pre-warmed (37°C) saline (0.5 ml) was instilled into the peritoneal cavity before closed with a suture. At 10 min after the onset of reperfusion, hTF-KI mice were randomized into 2 groups treated with either anti-hTF mAb (CNTO859, 5 mg/kg) or saline at same volume (2.5 ml/kg) through the jugular vein. Anesthesia and ventilation were terminated after treatment. All animals were left on spontaneous breathing during the 2 h of reperfusion, and then sacrificed by exsanguinations. The blood, lung and intestine tissues, and bronchoalveolar lavage (BAL) fluid were collected for further analysis. The experimental protocol was approved by the Toronto General Hospital Animal Care and Use Committee. All mice received care in compliance with the Principles of Laboratory Animal Care formulated by the National Society for Medical Research, and the Guide for the Care and Use of Experimental Animals formulated by the Canadian Council on Animal Care.</p>


<h4>Histology and immunostaining</h4>
<a id="article1.body1.sec2.sec4.p1" name="article1.body1.sec2.sec4.p1"></a><p>A stretch of intestine from the middle of IR-challenged area and the right lungs were fixed in 10% formalin <a href="#pone.0001527-Mura2">[20]</a> and subjected for histological examination and immunostaining. Hematoxylin and eosin (H&amp;E) staining was conducted with 5 µm tissue slides. The lung injury was assessed with modified scoring systems by a blinded pathologist according to the presence and extent of interstitial cellular infiltration, alveolar wall edema, hemorrhage, and atelectasis <a href="#pone.0001527-He1">[21]</a>.</p>
<a id="article1.body1.sec2.sec4.p2" name="article1.body1.sec2.sec4.p2"></a><p>Immunostaining was performed for von Willebrand factor (vWF) in the lung tissue. Briefly, the lung sections at 5 µm thickness were blocked with 5% BSA (Sigma, Oakville, Canada) in PBS for 30 min at 37°C after deparaffinization and dehydration. The slides were then incubated with rabbit anti-vWF polyclonal antibody (1:600 in 1% BSA, Dako, Mississauga, Canada) at 4°C overnight. ABC System (Vector Laboratories, Burlingame, CA) was used with a biotinylated goat anti-rabbit IgG (1:200) as the secondary antibody and permanent red as the chromogen. The specificity of the antibody was determined by replacing the primary antibody with non-immunized IgG (Sigma).</p>


<h4>Cell counting and protein in BAL fluid</h4>
<a id="article1.body1.sec2.sec5.p1" name="article1.body1.sec2.sec5.p1"></a><p>After ligation of the right bronchus, BAL was performed in the left lung by gently instilling and aspirating 0.25 ml saline through an intratracheal tube 2 times. An aliquot (20 µl) of BAL fluid from each animal was diluted with trypan blue (1:1) for total cell counting with a hemocytometer. The rest of the fluid was centrifuged (4,000 g, 10 min), and a Bradford protein assay (Bio-Rad, Hercules, CA) was conducted for the protein concentration in the supernatant <a href="#pone.0001527-Mura2">[20]</a>.</p>


<h4>Evans blue dye (EBD) assay and wet/dry (W/D) lung weight ratio</h4>
<a id="article1.body1.sec2.sec6.p1" name="article1.body1.sec2.sec6.p1"></a><p>The lower lobes of the right lungs were collected and dehydrated at 60°C for 72 h in a vacuum oven. The wet and dry weights were measured to calculate the W/D ratio. The EBD assay was conducted as previously reported <a href="#pone.0001527-Mura2">[20]</a>. Evans blue dye (30 mg/kg, Sigma) was administered via jugular vein 30 min before the experiment terminated. After flushing with 10 ml of PBS, the extravasation of EBD in the lung tissues was extracted, and determined at 620 nm.</p>


<h4>Coagulation Assays</h4>
<a id="article1.body1.sec2.sec7.p1" name="article1.body1.sec2.sec7.p1"></a><p>Activities of hTF and plasminogen activator inhibitor-1 (PAI-1) in the plasma were analyzed with a colorimetric assay according to the manufacturer's recommendations (American Diagnostica, Stamford, CT). Fibrin deposition was stained with Martius Scarlet Blue (MSB) using a standard protocol <a href="#pone.0001527-Olsen1">[22]</a>.</p>


<h4>Electron microscopy</h4>
<a id="article1.body1.sec2.sec8.p1" name="article1.body1.sec2.sec8.p1"></a><p>After IIR challenge, fresh lung biopsies were taken for electron microscopy. The samples were fixed with 2% glutaraldehyde in 0.1 M sodium cacodylate buffer, post-fixed with 1% osmium tetroxide in the same buffer, dehydrated in graded ethanol series, and embedded in Spurr epoxy resin. The embedded tissues were thin-sectioned, mounted on copper grids, and stained with uranyl acetate and lead citrate, as previously described <a href="#pone.0001527-Mura1">[19]</a>, <a href="#pone.0001527-Mura2">[20]</a>, <a href="#pone.0001527-Fischer1">[23]</a>, <a href="#pone.0001527-Quadri1">[24]</a>. Photographs were taken with an FEI CM100 Electron Microscope (FEI Company, Hillsboro, Oregon) equipped with a Kodak MegaPlus digital camera.</p>


<h4>Cytokine/chemokine measurement</h4>
<a id="article1.body1.sec2.sec9.p1" name="article1.body1.sec2.sec9.p1"></a><p>Tumor necrosis factor α (TNFα), interleukin (IL)-6, IL-10, monocyte chemoattractant protein-1 (MCP-1), and Interferon-γ (IFN-γ) in BAL fluid and lung tissue homogenates were measured using a mouse inflammation kit of cytometric bead array according to the manufacture's instruction (BD Bioscience, Mississauga, Canada) <a href="#pone.0001527-Xu1">[25]</a>. In brief, an aliquot of 50 µl sample was incubated with 50 µl of mixed beads coated with capturing antibodies specific for the respective cytokines and 50 µl of PE-conjugated detection antibodies for 2 h at room temperature in dark. The beads were washed by adding 1 ml of wash buffer and centrifugation, and then re-suspended in 300 µl of wash buffer. The distinct fluorescence intensities of beads were determined with a flow cytometer, and the data acquired were converted to the concentrations of the cytokines using BD CBA software (Becton Dickinson).</p>


<h4>Terminal transferase dUTP nick end labeling (TUNEL) staining</h4>
<a id="article1.body1.sec2.sec10.p1" name="article1.body1.sec2.sec10.p1"></a><p>The lung cell death was assessed by TUNEL staining with <em>In Situ</em> Cell Death Detection Kit (Roche, Penzberg, Germany) following the manufacture's instruction <a href="#pone.0001527-Mura2">[20]</a>. Briefly, after deparaffinization and dehydration the slides were permeabilized with 10 µg/ml proteinase K in 10 mM Tris/HCl (pH 7.4) for 15 min, and stained with Tetramethylrhodamine (TMR)-labeled TUNEL-positive nucleotides and counterstained with Hoechst (Pierce) for 10 min. Slides pre-treated with DNase (3,000 U/ml in 40 mM Tris-HCl, pH 7.5, 1 mg/ml BSA) were served as a positive control. Slides for negative control were incubated with the label solution without terminal transferase. The TUNEL-positive cells were quantified from 10 optical fields (400x) randomly chosen from each slide (n = 4 animals/group).</p>


<h4>Caspase 3 activity assay</h4>
<a id="article1.body1.sec2.sec11.p1" name="article1.body1.sec2.sec11.p1"></a><p>Caspase 3 activity in the lung tissues was determined by measuring the fluorescence of cleaved caspase 3 substrate as described <a href="#pone.0001527-Mura1">[19]</a>, <a href="#pone.0001527-Quadri1">[24]</a>, <a href="#pone.0001527-Tang1">[26]</a>. Lung homogenate containing 200 µg of total protein was mixed with 125 µM fluorogenic substrate (Ac-DEVD-AMC, Chemicon, Temecula, CA) in a 96-well plate. The plate was incubated at 37°C for 60 min and the fluorescence intensity (excitation of 360 nm and emission of 460 nm) was monitored with a CytoFluor multi-well plate reader (PerSeptive Biosystems Series 4000, Framingham, MA). The enzyme activity was calculated against a standard curve generated with recombinant caspase 3 (Chemicon). Tissue lysates from hypothermic preserved rat donor lungs <a href="#pone.0001527-Quadri1">[24]</a> were used as positive controls for the assay.</p>


<h4>Statistical Analysis</h4>
<a id="article1.body1.sec2.sec12.p1" name="article1.body1.sec2.sec12.p1"></a><p>Statistical software SPSS version 11.5 (SPSS, Chicago, IL) was used for data analyzing. Data are presented as mean±standard deviation (SD). All parametric data were analyzed with un-paired two-tailed <em>t</em>-test. Non-parametric data (lung injury scores) were analyzed with Kruskall-Wallis test. P value &lt;0.05 is defined as significant.</p>

</div>

<div id="section3" class="section"><a id="s3" name="s3" toc="s3" title="Results"></a><h3>Results</h3>
<h4>Human tissue factor maintains normal coagulant activity in transgenic mice</h4>
<a id="article1.body1.sec3.sec1.p1" name="article1.body1.sec3.sec1.p1"></a><p>To test anti-TF therapy against hTF in vivo, we used the hTF-KI mice generated by replacing a portion of mTF gene with the open reading frame of hTF. The hTF-KI mice have a similar life span without abnormal pathology in comparison with wild type animals. The tissue distribution and expression levels of hTF in transgenic mice were similar to that of mTF in wild type mice, and no mTF expression was detected in the transgenic mice <a href="#pone.0001527-Snyder1">[16]</a>. The brain extract of hTF-KI mice expressed hTF at 64 ng/mg protein, a level comparable to that from the human brain extract at 80 ng/mg protein. Tested with a one-stage clotting assay, the brain extract from the hTF-KI mice showed a similar pro-coagulation activity as that from wild type mice or human brain tissue (<a href="#pone-0001527-g001">Fig. 1A</a>). These results suggest that hTF functionally substitutes mTF and maintains a normal coagulant activity in the hTF-KI mice.</p>
<div class="figure" id="pone-0001527-g001"><div class="img"><a name="pone-0001527-g001" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001527.g001&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001527" data-uri="info:doi/10.1371/journal.pone.0001527.g001"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001527.g001&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001527.g001/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001527.g001/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001527.g001/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001527.g001/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001527.g001.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001527.g001/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001527.g001/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001527.g001.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 1.  <span>Human tissue factor is functionally expressed in hTF-KI transgenic mice, and effectively and specifically inhibited by the anti-hTF mAb, CNTO859.</span></strong></p><a id="article1.body1.sec3.sec1.fig1.caption1.p1" name="article1.body1.sec3.sec1.fig1.caption1.p1"></a><p>Pro-coagulant activity of TF in brain extracts from either hTF-KI or wild type (WT) mice, or from human brain tissue was measured with a one-stage clotting assay, and a similar prothrombin time was seen in all brain extracts, indicating a functional replacement of mTF by hTF expressed in the hTF-KI mice (A). Anti-hTF antibody, CNTO859, dose-dependently inhibited TF pro-coagulant activity in the brain extracts from hTF-KI mice and human, but not wild type mice (B). The experiments were repeated three times, and representative data from one experiment are shown.</p>
<span>doi:10.1371/journal.pone.0001527.g001</span></div><a id="article1.body1.sec3.sec1.p2" name="article1.body1.sec3.sec1.p2"></a><p>When the humanized monoclonal antibody, CNTO859, was incubated with brain extracts from human or hTF-KI mice, it inhibited coagulation dose-dependently as measured by prothrombin time. The IC<sub>50</sub> of CNTO859 for the hTF-KI brain extract was similar to that for the human brain extract (0.045 vs. 0.05 µg/ml), supporting that the hTF activity from both samples were comparable. In contrast, this antibody had no effect on brain extract from wild type mice (<a href="#pone-0001527-g001">Fig. 1B</a>). When an anti-mTF antibody was used in the coagulation assay, an inhibition effect was found only on brain extract from wild type mice, but not that from hTF-KI mice (data not shown). These results further confirm the specificity of CNTO859 on hTF and the substitution of mTF by the hTF is complete in the hTF-KI mice.</p>


<h4>Administration of CNTO859 ameliorated IIR-induced ALI</h4>
<a id="article1.body1.sec3.sec2.p1" name="article1.body1.sec3.sec2.p1"></a><p>A clinically relevant model of extrapulmonary ARDS has been used to induce acute lung injury by intestinal ischemia-reperfusion in C57BL/6 mice, and a high mortality rate was observed in these studies during 4 h of reperfusion period when animals were ventilated with oxygen <a href="#pone.0001527-Mura1">[19]</a>, <a href="#pone.0001527-Mura2">[20]</a>. It is known that C57BL/6 mice are sensitive to hyperoxia <a href="#pone.0001527-Cho1">[27]</a>. In the present study, we used hTF-KI mice, which are of a hybrid strain of 129SvBrd (~20%) and C57BL/6 (~80%). We first conducted a pilot study with a modified protocol, in which animals were not subject to mechanical ventilation and pure oxygen during the reperfusion period. There was no mortality during the first 24 h of reperfusion (data not shown). The IIR challenge induced a significant intestinal (<a href="#pone-0001527-g002">Fig. 2A</a>) and lung injury (<a href="#pone-0001527-g002">Fig. 2C</a>) in hTF-KI mice, which are very similar to that in wild type mice (data not shown) and as observed in our previous study <a href="#pone.0001527-Mura1">[19]</a>, <a href="#pone.0001527-Mura2">[20]</a>. These results suggest that hTF not only substituted mTF for coagulation, but also may play a similar role in acute inflammatory response related to acute lung injury.</p>
<div class="figure" id="pone-0001527-g002"><div class="img"><a name="pone-0001527-g002" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001527.g002&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001527" data-uri="info:doi/10.1371/journal.pone.0001527.g002"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001527.g002&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001527.g002/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001527.g002/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001527.g002/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001527.g002/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001527.g002.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001527.g002/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001527.g002/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001527.g002.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 2.  <span>Administration of anti-hTF mAb ameliorated intestinal ischemia-reperfusion (IIR)-induced acute lung injury in hTF-KI mice.</span></strong></p><a id="article1.body1.sec3.sec2.fig1.caption1.p1" name="article1.body1.sec3.sec2.fig1.caption1.p1"></a><p>IIR challenged hTF-KI mice were treated with CNTO859 (5 mg/kg, i.v.) or saline. The representative histology (H&amp;E, x400) from the intestine (A, B) and lung (C, D) was shown. The lung injury was scored by a pathologist in a blind fashion (E) (▪ inflammatory cells infiltration; ▪ alveolar wall edema; ▪ hemorrhage; atelectasis). □ Lung injury scores of 4 categories were analyzed with Kruskall-Wallis test, n = 4 animals/group, *: <em>p</em>&lt;0.05. The pulmonary permeability was determined by Evans Blue dye assay (F, G, H). Administration of CNTO859 also reduced the wet/dry lung weight ratio (I), albumin concentration (J), and total cell counts (K) in the BAL fluid. Panels I-K: n = 4 animals/group,*: <em>p</em>&lt;0.05, un-paired <em>t</em>-test.</p>
<span>doi:10.1371/journal.pone.0001527.g002</span></div><a id="article1.body1.sec3.sec2.p2" name="article1.body1.sec3.sec2.p2"></a><p>We then used this modified IIR model to test the effects of anti-hTF antibody in acute lung injury. The IIR-induced ALI in the hTF-KI mice was characterized by increased pulmonary interstitial edema (alveolar wall thickening), inflammatory cell infiltration, hemorrhage, and atelectasis. Administration of anti-hTF antibody, CNTO859, markedly ameliorated the IIR-induced ALI (<a href="#pone-0001527-g002">Fig. 2D</a>) in hTF-KI mice with a significantly lower injury score (p&lt;0.05, <a href="#pone-0001527-g002">Fig. 2E</a>).</p>
<a id="article1.body1.sec3.sec2.p3" name="article1.body1.sec3.sec2.p3"></a><p>One of the major features of ALI/ARDS is the increase in pulmonary permeability <a href="#pone.0001527-Mura3">[28]</a>, <a href="#pone.0001527-Okutani1">[29]</a>. A significant blockage of Evans Blue Dye leaking was seen in the lung treated with CNTO859 (<a href="#pone-0001527-g002">Fig. 2F–H</a>). This effect was confirmed with lung wet/dry weight ratio (<a href="#pone-0001527-g002">Fig. 2I</a>). The albumin content and total cell counts in the BAL fluid were significantly lower in CNTO859-treated group than in saline-treated group (<a href="#pone-0001527-g002">Fig. 2J and 2K</a>).</p>


<h4>Anti-TF mAb treatment attenuated IIR-induced coagulopathy</h4>
<a id="article1.body1.sec3.sec3.p1" name="article1.body1.sec3.sec3.p1"></a><p>It is known that activation of TF can trigger a pro-coagulation status, and lead to fibrin deposition in the lung. Administration of CNTO859 significantly reduced both TF and PAI-1 activities in the plasma (<a href="#pone-0001527-g003">Fig. 3A and 3B</a>), and dramatically attenuated the IIR-induced alveolar fibrin deposition (<a href="#pone-0001527-g003">Fig. 3C and 3D</a>).</p>
<div class="figure" id="pone-0001527-g003"><div class="img"><a name="pone-0001527-g003" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001527.g003&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001527" data-uri="info:doi/10.1371/journal.pone.0001527.g003"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001527.g003&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001527.g003/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001527.g003/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001527.g003/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001527.g003/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001527.g003.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001527.g003/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001527.g003/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001527.g003.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 3.  <span>Anti-hTF mAb treatment attenuated IIR induced coagulapathy and protected pulmonary endothelium.</span></strong></p><a id="article1.body1.sec3.sec3.fig1.caption1.p1" name="article1.body1.sec3.sec3.fig1.caption1.p1"></a><p>Plasma TF and PAI-1 activities were determined as described in <a href="#s2">Methods</a>. Administration of CNTO859 significantly inhibited both TF (A) and PAI-1 (B) activities in comparison with the saline treated control (*: <em>p</em>&lt;0.05, n = 4 animals/group, un-paired t-test). The fibrin staining showed that CNTO859 ameliorated IIR-induced fibrin deposition (pink) in the alveoli (C, D). The lung tissues were stained for vWF, a specific marker for endothelial integrity. Weaker staining of vWF (pink) of endothelium in the pulmonary vessels was noted in the saline control group (E). In CNTO859 treated animals stronger vWF staining was observed in the endothelium of pulmonary vessels (F). The pulmonary endothelial injury was further examined with electron microscopy. IIR challenge led to significant endothelial cell swelling (G), which was protected by CNTO859 treatment (H).</p>
<span>doi:10.1371/journal.pone.0001527.g003</span></div><a id="article1.body1.sec3.sec3.p2" name="article1.body1.sec3.sec3.p2"></a><p>Endothelium damage is an important mechanism responsible for the increase of pulmonary permeability <a href="#pone.0001527-Mura3">[28]</a>, <a href="#pone.0001527-Okutani1">[29]</a>. vWF is an endothelial specific marker, which is expressed mainly in larger vessels in normal lung tissue <a href="#pone.0001527-Muller1">[30]</a>, <a href="#pone.0001527-Pusztaszeri1">[31]</a>. In control animals, IIR challenge markedly reduced vWF immunostaining in larger pulmonary vessels (<a href="#pone-0001527-g003">Fig. 3E</a>). EM showed swelling of the cytoplasm, nucleus, and mitochondria of the endothelial cells in micro capillaries (<a href="#pone-0001527-g003">Fig. 3G</a>). In CNTO859 treated animals, vWF staining was clearly stronger in the endothelial layer of larger pulmonary vessels (<a href="#pone-0001527-g003">Fig. 3F</a>). The morphology of endothelial cells in pulmonary capillaries was better preserved (<a href="#pone-0001527-g003">Fig. 3H</a>).</p>


<h4>Anti-TF mAb treatment reduced inflammatory response and cell death in the lung</h4>
<a id="article1.body1.sec3.sec4.p1" name="article1.body1.sec3.sec4.p1"></a><p>Acute inflammatory response is a hallmark of ALI. CNTO859 treatment significantly reduced the levels of IL-6 and TNFα, and MCP-1 in the lung tissue (<a href="#pone-0001527-g004">Fig. 4A–C</a>). The IL-6 levels in BALF (<a href="#pone-0001527-g004">Fig. 4D</a>) were significantly reduced by CNTO859. However, the levels of IL-10, an anti-inflammatory cytokine, did not change in BALF (<a href="#pone-0001527-g004">Fig. 4E</a>), suggesting that the anti-inflammatory effect of CNTO859 is not through up-regulation of IL-10.</p>
<div class="figure" id="pone-0001527-g004"><div class="img"><a name="pone-0001527-g004" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001527.g004&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001527" data-uri="info:doi/10.1371/journal.pone.0001527.g004"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001527.g004&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001527.g004/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001527.g004/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001527.g004/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001527.g004/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001527.g004.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001527.g004/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001527.g004/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001527.g004.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 4.  <span>Anti-hTF mAb treatment reduced inflammatory response.</span></strong></p><a id="article1.body1.sec3.sec4.fig1.caption1.p1" name="article1.body1.sec3.sec4.fig1.caption1.p1"></a><p>Inflammatory cytokines were measured in the lung tissues and BAL fluid with a cytometric bead array. The expression levels of IL-6 (A), TNFα (B), and MCP-1 (C) in the lung tissues were significantly reduced by CNTO859 in comparison to saline group. In the BAL fluid CNTO859 also reduced the IL-6 levels (D), but the IL-10 level remained unchanged between the two groups (E). Un-paired t-test was used, *: <em>p</em>&lt;0.05, n = 4 animals/group.</p>
<span>doi:10.1371/journal.pone.0001527.g004</span></div><a id="article1.body1.sec3.sec4.p2" name="article1.body1.sec3.sec4.p2"></a><p>In a previous study, we found that IIR induces alveolar epithelial cell death <a href="#pone.0001527-Mura1">[19]</a>. In the present study, TUNEL positive cells were found in the lung of hTF-KI mice after IIR challenge (<a href="#pone-0001527-g005">Fig. 5A</a>), and they were significantly reduced by CNTO859 treatment (<a href="#pone-0001527-g005">Fig. 5B and 5C</a>). Caspase 3 is a key enzyme for apoptotic cell death. CNTO859 treatment reduced caspase 3 activity in lung tissue homogenates (<a href="#pone-0001527-g005">Fig. 5D</a>).</p>
<div class="figure" id="pone-0001527-g005"><div class="img"><a name="pone-0001527-g005" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001527.g005&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001527" data-uri="info:doi/10.1371/journal.pone.0001527.g005"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001527.g005&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001527.g005/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001527.g005/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001527.g005/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001527.g005/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001527.g005.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001527.g005/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001527.g005/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001527.g005.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 5.  <span>Anti-hTF mAb treatment reduced cell death.</span></strong></p><a id="article1.body1.sec3.sec4.fig2.caption1.p1" name="article1.body1.sec3.sec4.fig2.caption1.p1"></a><p>IIR-induced cell death in the lungs was determined by TUNEL staining. CNTO859 effect on the cell death was shown in representative slides (400x) (A, B), and quantified by counting the TUNEL positive cells from 10 randomly chosen fields (C). Caspase 3 activity in the lung tissue was also reduced by the anti-hTF antibody treatment (D). Un-paired t-test was used, 4 animals per group, *: <em>p</em>&lt;0.05.</p>
<span>doi:10.1371/journal.pone.0001527.g005</span></div>
</div>

<div id="section4" class="section"><a id="s4" name="s4" toc="s4" title="Discussion"></a><h3>Discussion</h3><a id="article1.body1.sec4.p1" name="article1.body1.sec4.p1"></a><p>Using transgenic mice to test efficacy of antibodies raised against human proteins is an attractive and important concept. There are only a few reports of using this strategy, thus, the results from the present study provide more insights for further development of this novel and useful model methodology.</p>
<a id="article1.body1.sec4.p2" name="article1.body1.sec4.p2"></a><p>Tissue factor, also named as thromboplastin, CD-142, and coagulation factor III, is a single chain membrane glycoprotein that functions as a receptor for Factor VII and VIIa and thereby initiates the extrinsic pathway of the coagulation cascade in response to vascular injury <a href="#pone.0001527-Davie1">[32]</a>, <a href="#pone.0001527-Morrissey1">[33]</a>. TF is generally localized in the adventitial fibroblasts of blood vessels, and initiates a rapid coagulation process when exposed to blood at the site of vessel injury, thereby limiting blood loss and maintaining hemostasis <a href="#pone.0001527-Luther1">[34]</a>. A compatibility study showed that hTF can bind to murine Factor VIIa with high affinity to induce coagulation <a href="#pone.0001527-Petersen1">[35]</a>, while mTF binds poorly to human Factor VIIa <a href="#pone.0001527-Petersen1">[35]</a>, <a href="#pone.0001527-Fang1">[36]</a>. Our hTF-KI transgenic mice showed expression of hTF at a physiological level that is fully compatible to normal lifespan, coagulation function <a href="#pone.0001527-Snyder1">[16]</a> and similar inflammatory response upon IIR. The substitution or replacement of a murine protein with its human counterpart is crucial for evaluating human-specific therapeutic agents in murine models. The specificity and efficacy of the humanized monoclonal antibody is also critically important. The anti-hTF monoclonal antibody, CNTO859, specifically binds to hTF <a href="#pone.0001527-Ngo1">[17]</a>, and inhibits the hTF activation in brain extracts from human tissue and the hTF-KI transgenic mice, but not from wild type littermate mice. It should be mentioned that we used the antibody CNTO859 at a very high dose (20 mg/kg) in our preliminary experiments, and observed no significant haemorrhage in the treated animals, indicating the safety of the antibody (data not shown). These features are important for its potential clinical application in the future.</p>
<a id="article1.body1.sec4.p3" name="article1.body1.sec4.p3"></a><p>ARDS is a multi-factorial syndrome with similar pathological manifestations but distinct underlying mechanisms <a href="#pone.0001527-Liu1">[1]</a>. Anti-TF therapy is attractive not only because of TF's role in the coagulation cascade, but also because of its pivotal role in the interplay with inflammatory signaling. TF binding to Factor VIIa leads to activation of Factor X, forming a transient ternary complex, which activates coagulation, thus resulting in thrombin generation, and ultimately the clot formation. This complex has been demonstrated as being critical for presenting Factor VIIa and Factor Xa to PARs on the cell surface. Cleavage of PARs initiates the inflammatory rather than coagulant activities of TF, including upregulation of cytokine gene expression <a href="#pone.0001527-Riewald1">[7]</a>, <a href="#pone.0001527-Camerer1">[9]</a>, <a href="#pone.0001527-WeltyWolf1">[14]</a>. The requirement of TF as a co-receptor for PAR1 and PAR2 activation is likely to be a key determinant <a href="#pone.0001527-Pawlinski1">[37]</a>. Recently, evidence showed the cytoplasmic domain of TF is also involved in chemotaxis regulation <a href="#pone.0001527-Siegbahn1">[38]</a>.</p>
<a id="article1.body1.sec4.p4" name="article1.body1.sec4.p4"></a><p>In the present study, we used IIR to induce ALI in hTF-KI mice. This is a clinically relevant model in which the severe intestinal damage is the initial insult. The lung is the most vulnerable remote organ after IIR, although cell death and inflammation have been noted in other vital organs <a href="#pone.0001527-Mura2">[20]</a>. This model has added value to other studies related to anti-TF therapies. Our data show a significant attenuation of the lung injury induced by IIR. The pulmonary permeability barrier consists of capillary endothelial and alveolar epithelial cells. Damage could occur on both sides of the alveolar walls during ALI <a href="#pone.0001527-Ware2">[39]</a>. In the present study, administration of anti-hTF antibody not only protected pulmonary endothelium from severe injury, but also significantly reduced cell death in the lung tissue, which mainly happens in alveolar epithelial cells upon IIR challenge <a href="#pone.0001527-Mura2">[20]</a>. Thus, anti-TF therapy may have protective effects on both endothelial and epithelial layers of alveolar walls. Ideally, a humanized IgG, instead of normal saline should be used for comparison with CNT0859, to exclude non-specific IgG effects. Our studies were limited by the availability of this agent; the results should be interpreted with caution.</p>
<a id="article1.body1.sec4.p5" name="article1.body1.sec4.p5"></a><p>The pulmonary level of TF expression has been found especially high relative to other organs. The TF levels in pulmonary edema fluid were found to be more than 100-fold higher than that in the plasma in patients with ALI/ARDS, indicating a local hypercoagulation status and tissue damages in the lung. The TF expression and activity in lung alveolar epithelial cells was increased by pro-inflammatory cytokines (e.g. TNFα and IL-1ß) <a href="#pone.0001527-Bastarache1">[40]</a>. We speculate that local administration of an anti-TF antibody may have direct benefits to ameliorate ALI, especially injury induced by intrapulmonary insults, such as acid aspiration and lung transplantation.</p>
<a id="article1.body1.sec4.p6" name="article1.body1.sec4.p6"></a><p>The hTF-KI animals and the specific antibody may offer us a useful model system to better characterize and understand the effects of anti-TF therapy in ALI models induced by other insults, such as sepsis, ventilator-induced lung injury, bacterial infection, etc. Results from these studies may provide additional information about the role of TF, as well as the potential therapeutic efficacy of CNTO859. Using small animals, we will be able to collect critical data prior to studies in non-human primates and clinical trials. This strategy should be considered for the development of species-specific therapeutic reagents for ALI/ARDS and other human diseases.</p>
<a id="article1.body1.sec4.p7" name="article1.body1.sec4.p7"></a><p>In summary, this study demonstrated the potential therapeutic effects of anti-TF strategy on ALI/ARDS with a new anti-TF monoclonal antibody. The new experimental strategy of using humanized antibody against human TF in transgenic mice offers a useful tool for further assessing the anti-TF therapy in preclinical trials for ARDS as well as other diseases related to the function of tissue factor.</p>
</div>





<div><a id="ack" name="ack" toc="ack" title="Acknowledgments"></a><h3>Acknowledgments</h3>
<a id="article1.back1.ack1.p1" name="article1.back1.ack1.p1"></a><p>We thank Dr. Huadong Zhu for his participation in the animal experiments; Ms. Suzanne Beaudin and Dr. Patricia C. Y. Liaw in Henderson Research Centre, McMaster University, Hamilton, Ontario, Canada for assistance on measurement of multiple mouse inflammatory cytokines.</p>
</div><div class="contributions"><a id="authcontrib" name="authcontrib" toc="authcontrib" title="Author Contributions"></a><h3>Author Contributions</h3><p>Conceived and designed the experiments: LL ML BH XH MM. Performed the experiments: BH XH MM MC AS KP JY. Analyzed the data: ML BH XH MC AS KP JY. Contributed reagents/materials/analysis tools: LL AS KP JY. Wrote the paper: ML BH XH.</p></div><div><a id="references" name="references" toc="references" title="References"></a><h3>References</h3><ol class="references"><li><span class="label">1.
              </span><a name="pone.0001527-Liu1" id="pone.0001527-Liu1"></a>Liu M (2005) Searching for acute respiratory distress syndrome genes: aren't we there yet? Am J Respir Crit Care Med  171: 298–299.  <ul class="find" data-citedArticleID="1049222" data-doi="10.1164/rccm.2412002"><li><a href="http://dx.doi.org/10.1164/rccm.2412002" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Searching+for+acute+respiratory+distress+syndrome+genes%3A+aren%27t+we+there+yet%3F" target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Searching+for+acute+respiratory+distress+syndrome+genes%3A+aren%27t+we+there+yet%3F%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">2.
              </span><a name="pone.0001527-Rijneveld1" id="pone.0001527-Rijneveld1"></a>Rijneveld AW, Weijer S, Bresser P, Florquin S, Vlasuk GP, et al.  (2006) Local activation of the tissue factor-factor VIIa pathway in patients with pneumonia and the effect of inhibition of this pathway in murine pneumococcal pneumonia. Crit Care Med  34: 1725–1730.  <ul class="find" data-citedArticleID="1049254" data-doi="10.1097/01.ccm.0000218807.20570.c2"><li><a href="http://dx.doi.org/10.1097/01.ccm.0000218807.20570.c2" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Local+activation+of+the+tissue+factor-factor+VIIa+pathway+in+patients+with+pneumonia+and+the+effect+of+inhibition+of+this+pathway+in+murine+pneumococcal+pneumonia." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Local+activation+of+the+tissue+factor-factor+VIIa+pathway+in+patients+with+pneumonia+and+the+effect+of+inhibition+of+this+pathway+in+murine+pneumococcal+pneumonia.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">3.
              </span><a name="pone.0001527-Abraham1" id="pone.0001527-Abraham1"></a>Abraham E (2000) Coagulation abnormalities in acute lung injury and sepsis. Am J Respir Cell Mol Biol  22: 401–404.  <ul class="find" data-citedArticleID="1049196" data-doi="10.1165/ajrcmb.22.4.f184"><li><a href="http://dx.doi.org/10.1165/ajrcmb.22.4.f184" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Coagulation+abnormalities+in+acute+lung+injury+and+sepsis." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Coagulation+abnormalities+in+acute+lung+injury+and+sepsis.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">4.
              </span><a name="pone.0001527-Carraway1" id="pone.0001527-Carraway1"></a>Carraway MS, Welty-Wolf KE, Miller DL, Ortel TL, Idell S, et al.  (2003) Blockade of tissue factor: treatment for organ injury in established sepsis. Am J Respir Crit Care Med  167: 1200–1209.  <ul class="find" data-citedArticleID="1049204" data-doi="10.1164/rccm.200204-287oc"><li><a href="http://dx.doi.org/10.1164/rccm.200204-287oc" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Blockade+of+tissue+factor%3A+treatment+for+organ+injury+in+established+sepsis." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Blockade+of+tissue+factor%3A+treatment+for+organ+injury+in+established+sepsis.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">5.
              </span><a name="pone.0001527-Schultz1" id="pone.0001527-Schultz1"></a>Schultz MJ, Millo J, Levi M, Hack CE, Weverling GJ, et al.  (2004) Local activation of coagulation and inhibition of fibrinolysis in the lung during ventilator associated pneumonia. Thorax  59: 130–135.  <ul class="find" data-citedArticleID="1049256" data-doi="10.1136/thorax.2003.013888"><li><a href="http://dx.doi.org/10.1136/thorax.2003.013888" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Local+activation+of+coagulation+and+inhibition+of+fibrinolysis+in+the+lung+during+ventilator+associated+pneumonia." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Local+activation+of+coagulation+and+inhibition+of+fibrinolysis+in+the+lung+during+ventilator+associated+pneumonia.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">6.
              </span><a name="pone.0001527-Choi1" id="pone.0001527-Choi1"></a>Choi G, Wolthuis EK, Bresser P, Levi M, van der Poll T, et al.  (2006) Mechanical Ventilation with Lower Tidal Volumes and Positive End-expiratory Pressure Prevents Alveolar Coagulation in Patients without Lung Injury. Anesthesiology  105: 689–695.  <ul class="find" data-citedArticleID="1049208" data-doi="10.1097/00000542-200610000-00013"><li><a href="http://dx.doi.org/10.1097/00000542-200610000-00013" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Mechanical+Ventilation+with+Lower+Tidal+Volumes+and+Positive+End-expiratory+Pressure+Prevents+Alveolar+Coagulation+in+Patients+without+Lung+Injury." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Mechanical+Ventilation+with+Lower+Tidal+Volumes+and+Positive+End-expiratory+Pressure+Prevents+Alveolar+Coagulation+in+Patients+without+Lung+Injury.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">7.
              </span><a name="pone.0001527-Riewald1" id="pone.0001527-Riewald1"></a>Riewald M, Ruf W (2001) Mechanistic coupling of protease signaling and initiation of coagulation by tissue factor. Proc Natl Acad Sci U S A  98: 7742–7747.  <ul class="find" data-citedArticleID="1049252" data-doi="10.1073/pnas.141126698"><li><a href="http://dx.doi.org/10.1073/pnas.141126698" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Mechanistic+coupling+of+protease+signaling+and+initiation+of+coagulation+by+tissue+factor." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Mechanistic+coupling+of+protease+signaling+and+initiation+of+coagulation+by+tissue+factor.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">8.
              </span><a name="pone.0001527-Coughlin1" id="pone.0001527-Coughlin1"></a>Coughlin SR (2000) Thrombin signalling and protease-activated receptors. Nature  407: 258–264.  <ul class="find" data-citedArticleID="1049210"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Thrombin+signalling+and+protease-activated+receptors.&amp;auth=&amp;atitle=Thrombin+signalling+and+protease-activated+receptors." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Thrombin+signalling+and+protease-activated+receptors." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Thrombin+signalling+and+protease-activated+receptors.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">9.
              </span><a name="pone.0001527-Camerer1" id="pone.0001527-Camerer1"></a>Camerer E, Huang W, Coughlin SR (2000) Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. Proc Natl Acad Sci U S A  97: 5255–5260.  <ul class="find" data-citedArticleID="1049202" data-doi="10.1073/pnas.97.10.5255"><li><a href="http://dx.doi.org/10.1073/pnas.97.10.5255" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Tissue+factor-+and+factor+X-dependent+activation+of+protease-activated+receptor+2+by+factor+VIIa." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Tissue+factor-+and+factor+X-dependent+activation+of+protease-activated+receptor+2+by+factor+VIIa.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">10.
              </span><a name="pone.0001527-Levi1" id="pone.0001527-Levi1"></a>Levi M, van der Poll T, Buller HR (2004) Bidirectional relation between inflammation and coagulation. Circulation  109: 2698–2704.  <ul class="find" data-citedArticleID="1049220" data-doi="10.1161/01.cir.0000131660.51520.9a"><li><a href="http://dx.doi.org/10.1161/01.cir.0000131660.51520.9a" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Bidirectional+relation+between+inflammation+and+coagulation." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Bidirectional+relation+between+inflammation+and+coagulation.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">11.
              </span><a name="pone.0001527-Ware1" id="pone.0001527-Ware1"></a>Ware LB, Camerer E, Welty-Wolf K, Schultz MJ, Matthay MA (2006) Bench to bedside: targeting coagulation and fibrinolysis in acute lung injury. Am J Physiol Lung Cell Mol Physiol  291: L307–311.  <ul class="find" data-citedArticleID="1049266" data-doi="10.1152/ajplung.00157.2006"><li><a href="http://dx.doi.org/10.1152/ajplung.00157.2006" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Bench+to+bedside%3A+targeting+coagulation+and+fibrinolysis+in+acute+lung+injury." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Bench+to+bedside%3A+targeting+coagulation+and+fibrinolysis+in+acute+lung+injury.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">12.
              </span><a name="pone.0001527-Schultz2" id="pone.0001527-Schultz2"></a>Schultz MJ, Haitsma JJ, Zhang H, Slutsky AS (2006) Pulmonary coagulopathy as a new target in therapeutic studies of acute lung injury or pneumonia–a review. Crit Care Med  34: 871–877.  <ul class="find" data-citedArticleID="1049258" data-doi="10.1097/01.ccm.0000201882.23917.b8"><li><a href="http://dx.doi.org/10.1097/01.ccm.0000201882.23917.b8" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Pulmonary+coagulopathy+as+a+new+target+in+therapeutic+studies+of+acute+lung+injury+or+pneumonia%E2%80%93a+review." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Pulmonary+coagulopathy+as+a+new+target+in+therapeutic+studies+of+acute+lung+injury+or+pneumonia%E2%80%93a+review.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">13.
              </span><a name="pone.0001527-Bernard1" id="pone.0001527-Bernard1"></a>Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, et al.  (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med  344: 699–709.  <ul class="find" data-citedArticleID="1049200" data-doi="10.1056/nejm200103083441001"><li><a href="http://dx.doi.org/10.1056/nejm200103083441001" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Efficacy+and+safety+of+recombinant+human+activated+protein+C+for+severe+sepsis." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Efficacy+and+safety+of+recombinant+human+activated+protein+C+for+severe+sepsis.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">14.
              </span><a name="pone.0001527-WeltyWolf1" id="pone.0001527-WeltyWolf1"></a>Welty-Wolf KE, Carraway MS, Miller DL, Ortel TL, Ezban M, et al.  (2001) Coagulation blockade prevents sepsis-induced respiratory and renal failure in baboons. Am J Respir Crit Care Med  164: 1988–1996.  <ul class="find" data-citedArticleID="1049270" data-doi="10.1164/ajrccm.164.10.2105027"><li><a href="http://dx.doi.org/10.1164/ajrccm.164.10.2105027" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Coagulation+blockade+prevents+sepsis-induced+respiratory+and+renal+failure+in+baboons." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Coagulation+blockade+prevents+sepsis-induced+respiratory+and+renal+failure+in+baboons.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">15.
              </span><a name="pone.0001527-WeltyWolf2" id="pone.0001527-WeltyWolf2"></a>Welty-Wolf KE, Carraway MS, Ortel TL, Ghio AJ, Idell S, et al.  (2006) Blockade of tissue factor-factor X binding attenuates sepsis-induced respiratory and renal failure. Am J Physiol Lung Cell Mol Physiol  290: L21–31.  <ul class="find" data-citedArticleID="1049272" data-doi="10.1152/ajplung.00155.2005"><li><a href="http://dx.doi.org/10.1152/ajplung.00155.2005" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Blockade+of+tissue+factor-factor+X+binding+attenuates+sepsis-induced+respiratory+and+renal+failure." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Blockade+of+tissue+factor-factor+X+binding+attenuates+sepsis-induced+respiratory+and+renal+failure.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">16.
              </span><a name="pone.0001527-Snyder1" id="pone.0001527-Snyder1"></a>Snyder LA, Rudnick KA, Tawadros R, Volk A, Tam SH, et al.  (2007) Expression of human tissue factor under the control of the mouse tissue factor promoter mediates normal hemostasis in knock-in mice. J Thromb Haemost.   <ul class="find" data-citedArticleID="1049262" data-doi="10.1111/j.1538-7836.2007.02833.x"><li><a href="http://dx.doi.org/10.1111/j.1538-7836.2007.02833.x" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Expression+of+human+tissue+factor+under+the+control+of+the+mouse+tissue+factor+promoter+mediates+normal+hemostasis+in+knock-in+mice." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Expression+of+human+tissue+factor+under+the+control+of+the+mouse+tissue+factor+promoter+mediates+normal+hemostasis+in+knock-in+mice.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">17.
              </span><a name="pone.0001527-Ngo1" id="pone.0001527-Ngo1"></a>Ngo CV, Picha K, McCabe F, Millar H, Tawadros R, et al.  (2007) CNTO 859, a humanized anti-tissue factor monoclonal antibody, is a potent inhibitor of breast cancer metastasis and tumor growth in xenograft models. Int J Cancer  120: 1261–1267.  <ul class="find" data-citedArticleID="1049236" data-doi="10.1002/ijc.22426"><li><a href="http://dx.doi.org/10.1002/ijc.22426" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=CNTO+859%2C+a+humanized+anti-tissue+factor+monoclonal+antibody%2C+is+a+potent+inhibitor+of+breast+cancer+metastasis+and+tumor+growth+in+xenograft+models." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22CNTO+859%2C+a+humanized+anti-tissue+factor+monoclonal+antibody%2C+is+a+potent+inhibitor+of+breast+cancer+metastasis+and+tumor+growth+in+xenograft+models.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">18.
              </span><a name="pone.0001527-Oltrona1" id="pone.0001527-Oltrona1"></a>Oltrona L, Speidel CM, Recchia D, Wickline SA, Eisenberg PR, et al.  (1997) Inhibition of tissue factor-mediated coagulation markedly attenuates stenosis after balloon-induced arterial injury in minipigs. Circulation  96: 646–652.  <ul class="find" data-citedArticleID="1049242" data-doi="10.1161/01.cir.96.2.646"><li><a href="http://dx.doi.org/10.1161/01.cir.96.2.646" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Inhibition+of+tissue+factor-mediated+coagulation+markedly+attenuates+stenosis+after+balloon-induced+arterial+injury+in+minipigs." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Inhibition+of+tissue+factor-mediated+coagulation+markedly+attenuates+stenosis+after+balloon-induced+arterial+injury+in+minipigs.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">19.
              </span><a name="pone.0001527-Mura1" id="pone.0001527-Mura1"></a>Mura M, Andrade CF, Han B, Seth R, Zhang Y, et al.  (2007) Intestinal I/R-Induced Acute Lung Injury and Oncotic Cell Death in Multiple Organs. Shock  28: 227–238.  <ul class="find" data-citedArticleID="1049230" data-doi="10.1097/01.shk.0000278497.47041.e3"><li><a href="http://dx.doi.org/10.1097/01.shk.0000278497.47041.e3" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Intestinal+I%2FR-Induced+Acute+Lung+Injury+and+Oncotic+Cell+Death+in+Multiple+Organs." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Intestinal+I%2FR-Induced+Acute+Lung+Injury+and+Oncotic+Cell+Death+in+Multiple+Organs.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">20.
              </span><a name="pone.0001527-Mura2" id="pone.0001527-Mura2"></a>Mura M, Han B, Andrade CF, Seth R, Hwang D, et al.  (2006) The early responses of VEGF and its receptors during acute lung injury: implication of VEGF in alveolar epithelial cell survival. Crit Care  10: R130.  <ul class="find" data-citedArticleID="1049232"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=The+early+responses+of+VEGF+and+its+receptors+during+acute+lung+injury%3A+implication+of+VEGF+in+alveolar+epithelial+cell+survival.&amp;auth=&amp;atitle=The+early+responses+of+VEGF+and+its+receptors+during+acute+lung+injury%3A+implication+of+VEGF+in+alveolar+epithelial+cell+survival." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=The+early+responses+of+VEGF+and+its+receptors+during+acute+lung+injury%3A+implication+of+VEGF+in+alveolar+epithelial+cell+survival." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22The+early+responses+of+VEGF+and+its+receptors+during+acute+lung+injury%3A+implication+of+VEGF+in+alveolar+epithelial+cell+survival.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">21.
              </span><a name="pone.0001527-He1" id="pone.0001527-He1"></a>He X, Han B, Mura M, Xia S, Wang S, et al.  (2007) Angiotensin-Converting Enzyme Inhibitor Captopril Prevents Oleic Acid-Induced Severe Acute Lung Injury in Rats. Shock  28: 106–111.  <ul class="find" data-citedArticleID="1049218" data-doi="10.1097/shk.0b013e3180310f3a"><li><a href="http://dx.doi.org/10.1097/shk.0b013e3180310f3a" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Angiotensin-Converting+Enzyme+Inhibitor+Captopril+Prevents+Oleic+Acid-Induced+Severe+Acute+Lung+Injury+in+Rats." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Angiotensin-Converting+Enzyme+Inhibitor+Captopril+Prevents+Oleic+Acid-Induced+Severe+Acute+Lung+Injury+in+Rats.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">22.
              </span><a name="pone.0001527-Olsen1" id="pone.0001527-Olsen1"></a>Olsen EG (1975) Repeated pulmonary thromboembolism in rabbits. Lab Invest  32: 323–329.  <ul class="find" data-citedArticleID="1049240"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Repeated+pulmonary+thromboembolism+in+rabbits.&amp;auth=&amp;atitle=Repeated+pulmonary+thromboembolism+in+rabbits." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Repeated+pulmonary+thromboembolism+in+rabbits." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Repeated+pulmonary+thromboembolism+in+rabbits.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">23.
              </span><a name="pone.0001527-Fischer1" id="pone.0001527-Fischer1"></a>Fischer S, Cassivi SD, Xavier AM, Cardella JA, Cutz E, et al.  (2000) Cell death in human lung transplantation: apoptosis induction in human lungs during ischemia and after transplantation. Ann Surg  231: 424–431.  <ul class="find" data-citedArticleID="1049216" data-doi="10.1097/00000658-200003000-00016"><li><a href="http://dx.doi.org/10.1097/00000658-200003000-00016" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Cell+death+in+human+lung+transplantation%3A+apoptosis+induction+in+human+lungs+during+ischemia+and+after+transplantation." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Cell+death+in+human+lung+transplantation%3A+apoptosis+induction+in+human+lungs+during+ischemia+and+after+transplantation.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">24.
              </span><a name="pone.0001527-Quadri1" id="pone.0001527-Quadri1"></a>Quadri SM, Segall L, de Perrot M, Han B, Edwards V, et al.  (2005) Caspase inhibition improves ischemia-reperfusion injury after lung transplantation. Am J Transplant  5: 292–299.  <ul class="find" data-citedArticleID="1049250" data-doi="10.1111/j.1600-6143.2004.00701.x"><li><a href="http://dx.doi.org/10.1111/j.1600-6143.2004.00701.x" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Caspase+inhibition+improves+ischemia-reperfusion+injury+after+lung+transplantation." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Caspase+inhibition+improves+ischemia-reperfusion+injury+after+lung+transplantation.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">25.
              </span><a name="pone.0001527-Xu1" id="pone.0001527-Xu1"></a>Xu J, Bai XH, Lodyga M, Han B, Xiao H, et al.  (2007) XB130, a novel adaptor protein for signal transduction. J Biol Chem  282: 16401–16412.  <ul class="find" data-citedArticleID="1049274" data-doi="10.1074/jbc.m701684200"><li><a href="http://dx.doi.org/10.1074/jbc.m701684200" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=XB130%2C+a+novel+adaptor+protein+for+signal+transduction." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22XB130%2C+a+novel+adaptor+protein+for+signal+transduction.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">26.
              </span><a name="pone.0001527-Tang1" id="pone.0001527-Tang1"></a>Tang PS, Tsang ME, Lodyga M, Bai XH, Miller A, et al.  (2006) Lipopolysaccharide accelerates caspase-independent but cathepsin B-dependent death of human lung epithelial cells. J Cell Physiol  209: 457–467.  <ul class="find" data-citedArticleID="1049264" data-doi="10.1002/jcp.20751"><li><a href="http://dx.doi.org/10.1002/jcp.20751" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Lipopolysaccharide+accelerates+caspase-independent+but+cathepsin+B-dependent+death+of+human+lung+epithelial+cells." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Lipopolysaccharide+accelerates+caspase-independent+but+cathepsin+B-dependent+death+of+human+lung+epithelial+cells.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">27.
              </span><a name="pone.0001527-Cho1" id="pone.0001527-Cho1"></a>Cho HY, Jedlicka AE, Reddy SP, Zhang LY, Kensler TW, et al.  (2002) Linkage analysis of susceptibility to hyperoxia. Nrf2 is a candidate gene. Am J Respir Cell Mol Biol  26: 42–51.  <ul class="find" data-citedArticleID="1049206" data-doi="10.1165/ajrcmb.26.1.4536"><li><a href="http://dx.doi.org/10.1165/ajrcmb.26.1.4536" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Linkage+analysis+of+susceptibility+to+hyperoxia.+Nrf2+is+a+candidate+gene." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Linkage+analysis+of+susceptibility+to+hyperoxia.+Nrf2+is+a+candidate+gene.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">28.
              </span><a name="pone.0001527-Mura3" id="pone.0001527-Mura3"></a>Mura M, dos Santos CC, Stewart D, Liu M (2004) Vascular endothelial growth factor and related molecules in acute lung injury. J Appl Physiol  97: 1605–1617.  <ul class="find" data-citedArticleID="1049234" data-doi="10.1152/japplphysiol.00202.2004"><li><a href="http://dx.doi.org/10.1152/japplphysiol.00202.2004" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Vascular+endothelial+growth+factor+and+related+molecules+in+acute+lung+injury." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Vascular+endothelial+growth+factor+and+related+molecules+in+acute+lung+injury.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">29.
              </span><a name="pone.0001527-Okutani1" id="pone.0001527-Okutani1"></a>Okutani D, Lodyga M, Han B, Liu M (2006) Src protein tyrosine kinase family and acute inflammatory responses. Am J Physiol Lung Cell Mol Physiol  291: L129–141.  <ul class="find" data-citedArticleID="1049238" data-doi="10.1152/ajplung.00261.2005"><li><a href="http://dx.doi.org/10.1152/ajplung.00261.2005" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Src+protein+tyrosine+kinase+family+and+acute+inflammatory+responses." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Src+protein+tyrosine+kinase+family+and+acute+inflammatory+responses.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">30.
              </span><a name="pone.0001527-Muller1" id="pone.0001527-Muller1"></a>Muller AM, Skrzynski C, Skipka G, Muller KM (2002) Expression of von Willebrand factor by human pulmonary endothelial cells in vivo. Respiration  69: 526–533.  <ul class="find" data-citedArticleID="1049228" data-doi="10.1159/000066471"><li><a href="http://dx.doi.org/10.1159/000066471" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Expression+of+von+Willebrand+factor+by+human+pulmonary+endothelial+cells+in+vivo." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Expression+of+von+Willebrand+factor+by+human+pulmonary+endothelial+cells+in+vivo.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">31.
              </span><a name="pone.0001527-Pusztaszeri1" id="pone.0001527-Pusztaszeri1"></a>Pusztaszeri MP, Seelentag W, Bosman FT (2006) Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues. J Histochem Cytochem  54: 385–395.  <ul class="find" data-citedArticleID="1049248" data-doi="10.1369/jhc.4a6514.2005"><li><a href="http://dx.doi.org/10.1369/jhc.4a6514.2005" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Immunohistochemical+expression+of+endothelial+markers+CD31%2C+CD34%2C+von+Willebrand+factor%2C+and+Fli-1+in+normal+human+tissues." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Immunohistochemical+expression+of+endothelial+markers+CD31%2C+CD34%2C+von+Willebrand+factor%2C+and+Fli-1+in+normal+human+tissues.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">32.
              </span><a name="pone.0001527-Davie1" id="pone.0001527-Davie1"></a>Davie EW, Fujikawa K, Kisiel W (1991) The coagulation cascade: initiation, maintenance, and regulation. Biochemistry  30: 10363–10370.  <ul class="find" data-citedArticleID="1049212" data-doi="10.1021/bi00107a001"><li><a href="http://dx.doi.org/10.1021/bi00107a001" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=The+coagulation+cascade%3A+initiation%2C+maintenance%2C+and+regulation." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22The+coagulation+cascade%3A+initiation%2C+maintenance%2C+and+regulation.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">33.
              </span><a name="pone.0001527-Morrissey1" id="pone.0001527-Morrissey1"></a>Morrissey JH (1995) Tissue factor modulation of factor VIIa activity: use in measuring trace levels of factor VIIa in plasma. Thromb Haemost  74: 185–188.  <ul class="find" data-citedArticleID="1049226"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Tissue+factor+modulation+of+factor+VIIa+activity%3A+use+in+measuring+trace+levels+of+factor+VIIa+in+plasma.&amp;auth=&amp;atitle=Tissue+factor+modulation+of+factor+VIIa+activity%3A+use+in+measuring+trace+levels+of+factor+VIIa+in+plasma." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Tissue+factor+modulation+of+factor+VIIa+activity%3A+use+in+measuring+trace+levels+of+factor+VIIa+in+plasma." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Tissue+factor+modulation+of+factor+VIIa+activity%3A+use+in+measuring+trace+levels+of+factor+VIIa+in+plasma.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">34.
              </span><a name="pone.0001527-Luther1" id="pone.0001527-Luther1"></a>Luther T, Flossel C, Mackman N, Bierhaus A, Kasper M, et al.  (1996) Tissue factor expression during human and mouse development. Am J Pathol  149: 101–113.  <ul class="find" data-citedArticleID="1049224"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Tissue+factor+expression+during+human+and+mouse+development.&amp;auth=&amp;atitle=Tissue+factor+expression+during+human+and+mouse+development." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Tissue+factor+expression+during+human+and+mouse+development." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Tissue+factor+expression+during+human+and+mouse+development.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">35.
              </span><a name="pone.0001527-Petersen1" id="pone.0001527-Petersen1"></a>Petersen LC, Norby PL, Branner S, Sorensen BB, Elm T, et al.  (2005) Characterization of recombinant murine factor VIIa and recombinant murine tissue factor: a human-murine species compatibility study. Thromb Res  116: 75–85.  <ul class="find" data-citedArticleID="1049246" data-doi="10.1016/j.thromres.2004.11.003"><li><a href="http://dx.doi.org/10.1016/j.thromres.2004.11.003" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Characterization+of+recombinant+murine+factor+VIIa+and+recombinant+murine+tissue+factor%3A+a+human-murine+species+compatibility+study." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Characterization+of+recombinant+murine+factor+VIIa+and+recombinant+murine+tissue+factor%3A+a+human-murine+species+compatibility+study.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">36.
              </span><a name="pone.0001527-Fang1" id="pone.0001527-Fang1"></a>Fang CH, Lin TC, Guha A, Nemerson Y, Konigsberg WH (1996) Activation of factor X by factor VIIa complexed with human-mouse tissue factor chimeras requires human exon 3. Thromb Haemost  76: 361–368.  <ul class="find" data-citedArticleID="1049214"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Activation+of+factor+X+by+factor+VIIa+complexed+with+human-mouse+tissue+factor+chimeras+requires+human+exon+3.&amp;auth=&amp;atitle=Activation+of+factor+X+by+factor+VIIa+complexed+with+human-mouse+tissue+factor+chimeras+requires+human+exon+3." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Activation+of+factor+X+by+factor+VIIa+complexed+with+human-mouse+tissue+factor+chimeras+requires+human+exon+3." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Activation+of+factor+X+by+factor+VIIa+complexed+with+human-mouse+tissue+factor+chimeras+requires+human+exon+3.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">37.
              </span><a name="pone.0001527-Pawlinski1" id="pone.0001527-Pawlinski1"></a>Pawlinski R, Pedersen B, Schabbauer G, Tencati M, Holscher T, et al.  (2004) Role of tissue factor and protease-activated receptors in a mouse model of endotoxemia. Blood  103: 1342–1347.  <ul class="find" data-citedArticleID="1049244" data-doi="10.1182/blood-2003-09-3051"><li><a href="http://dx.doi.org/10.1182/blood-2003-09-3051" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Role+of+tissue+factor+and+protease-activated+receptors+in+a+mouse+model+of+endotoxemia." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Role+of+tissue+factor+and+protease-activated+receptors+in+a+mouse+model+of+endotoxemia.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">38.
              </span><a name="pone.0001527-Siegbahn1" id="pone.0001527-Siegbahn1"></a>Siegbahn A, Johnell M, Sorensen BB, Petersen LC, Heldin CH (2005) Regulation of chemotaxis by the cytoplasmic domain of tissue factor. Thromb Haemost  93: 27–34.  <ul class="find" data-citedArticleID="1049260" data-doi="10.1160/th04-07-0405"><li><a href="http://dx.doi.org/10.1160/th04-07-0405" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Regulation+of+chemotaxis+by+the+cytoplasmic+domain+of+tissue+factor." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Regulation+of+chemotaxis+by+the+cytoplasmic+domain+of+tissue+factor.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">39.
              </span><a name="pone.0001527-Ware2" id="pone.0001527-Ware2"></a>Ware LB, Matthay MA (2000) The acute respiratory distress syndrome. N Engl J Med  342: 1334–1349.  <ul class="find" data-citedArticleID="1049268" data-doi="10.1056/nejm200005043421806"><li><a href="http://dx.doi.org/10.1056/nejm200005043421806" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=The+acute+respiratory+distress+syndrome." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22The+acute+respiratory+distress+syndrome.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">40.
              </span><a name="pone.0001527-Bastarache1" id="pone.0001527-Bastarache1"></a>Bastarache JA, Wang L, Geiser T, Wang Z, Albertine KH, et al.  (2007) The alveolar epithelium can initiate the extrinsic coagulation cascade through expression of tissue factor. Thorax  62: 608–616.  <ul class="find" data-citedArticleID="1049198" data-doi="10.1136/thx.2006.063305"><li><a href="http://dx.doi.org/10.1136/thx.2006.063305" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=The+alveolar+epithelium+can+initiate+the+extrinsic+coagulation+cascade+through+expression+of+tissue+factor." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22The+alveolar+epithelium+can+initiate+the+extrinsic+coagulation+cascade+through+expression+of+tissue+factor.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li></ol></div>

  </div>

      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001527.XML" value="79786"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001527.PDF" value="549086"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001527.g001.PNG_L" value="178221"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001527.g001.PNG_M" value="32800"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001527.g001.PNG_S" value="8759"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001527.g001.TIF" value="284868"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001527.g001.PNG_I" value="33241"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001527.g002.PNG_L" value="1845137"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001527.g002.PNG_M" value="272492"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001527.g002.PNG_S" value="18513"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001527.g002.TIF" value="2977000"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001527.g002.PNG_I" value="163309"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001527.g003.PNG_L" value="1560674"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001527.g003.PNG_M" value="237006"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001527.g003.PNG_S" value="23504"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001527.g003.TIF" value="2272206"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001527.g003.PNG_I" value="256325"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001527.g004.PNG_L" value="159066"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001527.g004.PNG_M" value="65394"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001527.g004.PNG_S" value="7947"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001527.g004.TIF" value="211846"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001527.g004.PNG_I" value="21263"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001527.g005.PNG_L" value="394838"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001527.g005.PNG_M" value="216251"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001527.g005.PNG_S" value="12358"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001527.g005.TIF" value="632536"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001527.g005.PNG_I" value="78464"/>

</div>
<div class="sidebar">

  <div class="article-actions cf">
      <div class="download">
        <span class="btn"><a href="/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0001527&amp;representation=PDF" title="Download" target="_blank">Download PDF</a></span>
      </div>
      <div class="btn-reveal dropdown">
        <div class="dropdown-icon">
          <span class="btn">&nbsp;</span>
        </div>

        <div class="content">
          <ul class="bullet">
            <li><a href="/article/citationList.action?articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0001527" title="Download citations">Citation</a></li>
            <li><a href="/article/fetchObjectAttachment.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0001527&amp;representation=XML" title="Download article XML">XML</a></li>
          </ul>
        </div>
      </div> <!-- end btn-reveal dropdown-->


    <div class="btn-reveal flt-l">
        <span class="btn">Print</span>
        <div class="content">
            <ul class="bullet">
                <li id="print-article"><a href="#" onclick="if(typeof(_gaq) != 'undefined'){ _gaq.push(['_trackEvent','Article', 'Print', 'Click']); } window.print(); return false;" title="Print Article">Print article</a></li>
                <li>
                  <a href="https://www.odysseypress.com/onlinehost/reprint_order.php?type=A&page=0&journal=7&doi=10.1371/journal.pone.0001527&volume=&issue=&title=Anti-Human Tissue Factor Antibody Ameliorated Intestinal Ischemia Reperfusion-Induced Acute Lung Injury in Human Tissue Factor Knock-In Mice&author_name=Xiaolin%20He%2C%20Bing%20Han%2C%20Marco%20Mura%2C%20Li%20Li%2C%20Marcelo%20Cypel%2C%20Avery%20Soderman%2C%20Kristen%20Picha%2C%20Jing%20Yang%2C%20Mingyao%20Liu&start_page=1&end_page=8" title="Odyssey Press">EzReprint</a>
                </li>
            </ul>
        </div>
    </div>

    <div class="btn-reveal flt-r">
        <span class="btn">Share</span>
        <div class="content">
            <ul class="social">
                <li><a href="http://www.reddit.com/submit?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001527" target="_blank" title="Submit to Reddit"><img src="/images/icon.reddit.16.png" width="16" height="16" alt="Reddit">Reddit</a></li>

                <li><a href="https://plus.google.com/share?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001527" target="_blank" title="Share on Google+"><img src="/images/icon.gplus.16.png" width="16" height="16" alt="Google+">Google+</a></li>

                <li><a href="http://www.stumbleupon.com/submit?url=http%3A%2F%2Fwww.plosone.org%2Farticle%2Finfo%253Adoi%252F10.1371%252Fjournal.pone.0001527" target="_blank" title="Add to StumbleUpon"><img src="/images/icon.stumble.16.png" width="16" height="16" alt="StumbleUpon">StumbleUpon</a></li>

                <li><a href="http://www.facebook.com/share.php?u=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001527&amp;t=Anti-Human%20Tissue%20Factor%20Antibody%20Ameliorated%20Intestinal%20Ischemia%20Reperfusion-Induced%20Acute%20Lung%20Injury%20in%20Human%20Tissue%20Factor%20Knock-In%20Mice" target="_blank" title="Share on Facebook"><img src="/images/icon.fb.16.png" width="16" height="16" alt="Facebook">Facebook</a></li>

                <li><a href="http://www.linkedin.com/shareArticle?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001527&title=Anti-Human%20Tissue%20Factor%20Antibody%20Ameliorated%20Intestinal%20Ischemia%20Reperfusion-Induced%20Acute%20Lung%20Injury%20in%20Human%20Tissue%20Factor%20Knock-In%20Mice&summary=Checkout%20this%20article%20I%20found%20at%20PLOS" target="_blank" title="Add to LinkedIn"><img src="/images/icon.linkedin.16.png" width="16" height="16" alt="Mendeley">LinkedIn</a></li>

                <li><a href="http://www.citeulike.org/posturl?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001527&amp;title=Anti-Human%20Tissue%20Factor%20Antibody%20Ameliorated%20Intestinal%20Ischemia%20Reperfusion-Induced%20Acute%20Lung%20Injury%20in%20Human%20Tissue%20Factor%20Knock-In%20Mice" target="_blank" title="Add to CiteULike"><img src="/images/icon.cul.16.png" width="16" height="16" alt="CiteULike">CiteULike</a></li>

                <li><a href="http://www.mendeley.com/import/?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001527" target="_blank" title="Add to Mendeley"><img src="/images/icon.mendeley.16.png" width="16" height="16" alt="Mendeley">Mendeley</a></li>

                <li><a href="https://www.pubchase.com/library?add_aid=10.1371%2Fjournal.pone.0001527&amp;source=plos" target="_blank" title="Add to PubChase"><img src="/images/icon.pc.16.png" width="16" height="16" alt="PubChase">PubChase</a></li>


                <script type="text/javascript">
                    // replace tweet with one that's pre-shortened to 140 chars
                    function truncateTweetText() {
                        var twtTitle = 'Anti-Human Tissue Factor Antibody Ameliorated Intestinal Ischemia Reperfusion-Induced Acute Lung Injury in Human Tissue Factor Knock-In Mice';
                        var twtUrl = 'http://dx.plos.org/10.1371/journal.pone.0001527';
                        // all URLs posted to twitter get auto-shortened to 20 chars.
                        var maxLength = 140 - (20 + 1);
                        // truncate the title to include space for twtTag and ellipsis (here, 10 = tag length + space + ellipsis)
                        if (twtTitle.length > maxLength) { twtTitle = twtTitle.substr(0, (maxLength - 10)) + '...'; }
                        // set the href to use the shortened tweet
                        $('#twitter-share-link').prop('href', 'http://twitter.com/intent/tweet?text=' + encodeURIComponent('#PLOSONE: ' + twtTitle + ' ' + twtUrl));
                    }
                </script>
                <li><a href="http://twitter.com/intent/tweet?text=#PLOSONE%3A%20Anti-Human%20Tissue%20Factor%20Antibody%20Ameliorated%20Intestinal%20Ischemia%20Reperfusion-Induced%20Acute%20Lung%20Injury%20in%20Human%20Tissue%20Factor%20Knock-In%20Mice http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001527" onclick="truncateTweetText();" target="_blank" title="Share on Twitter" id="twitter-share-link"><img src="/images/icon.twtr.16.png" width="16" height="16" alt="Twitter">Twitter</a></li>

                <li><a href="/article/email/info%3Adoi%2F10.1371%2Fjournal.pone.0001527" title="Email this article"><img src="/images/icon.email.16.png" width="16" height="16" alt="Email">Email</a></li>
            </ul>
        </div>
    </div><!--end btn-reveal flt-r-->
</div><!-- end article-actions-->

<!-- begin Crossmark -->

<a id="open-crossmark" href="#" style="margin-top: -28px; display:block"><img style="border: 0; display: none;
 padding: 10px 0 18px 0;"  id="crossmark-icon" src="/images/logo-crossmark-bw.png" /></a>
<div id="crossmark-dialog" style="display: none;" title="">
    <!-- the external CrossMark data is loaded inside this iframe -->
    <iframe id="crossmark-dialog-frame" frameborder="0"></iframe>
</div>

<!-- end crossmark -->


<div class="block" id="subject-area-sidebar-block">
    <div class="header">
        <h3>Subject Areas</h3><div title="More information" id="subject-area-sidebar-block-help-icon"><img align="right"
                                                                                                           alt="info" src="/images/button_info.png"/><div id="subject-area-sidebar-block-help"><img align="right"
                                                                                                                                                                                                    src="/images/button_info.png"/><p>
        <b>We want your feedback.</b> Do these subject areas make sense for this article? If not, click the flag
        next to the incorrect subject area and we will review it. Thanks for your help!
    </p></div></div>
    </div>


    <ul id="subject-area-sidebar-list">



















          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Cell+death%22" title="Search for articles in the subject area:'Cell death'"><div class="flagText">Cell death</div></a>
              <div data-categoryid="19339" data-articleid="25880"
                   data-categoryname="Cell death"
                   class="flagImage" title="Flag 'Cell death' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Cytokines%22" title="Search for articles in the subject area:'Cytokines'"><div class="flagText">Cytokines</div></a>
              <div data-categoryid="47517" data-articleid="25880"
                   data-categoryname="Cytokines"
                   class="flagImage" title="Flag 'Cytokines' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Fibrin%22" title="Search for articles in the subject area:'Fibrin'"><div class="flagText">Fibrin</div></a>
              <div data-categoryid="27369" data-articleid="25880"
                   data-categoryname="Fibrin"
                   class="flagImage" title="Flag 'Fibrin' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Inflammation%22" title="Search for articles in the subject area:'Inflammation'"><div class="flagText">Inflammation</div></a>
              <div data-categoryid="32301" data-articleid="25880"
                   data-categoryname="Inflammation"
                   class="flagImage" title="Flag 'Inflammation' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Monoclonal+antibodies%22" title="Search for articles in the subject area:'Monoclonal antibodies'"><div class="flagText">Monoclonal antibodies</div></a>
              <div data-categoryid="36093" data-articleid="25880"
                   data-categoryname="Monoclonal antibodies"
                   class="flagImage" title="Flag 'Monoclonal antibodies' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Mouse+models%22" title="Search for articles in the subject area:'Mouse models'"><div class="flagText">Mouse models</div></a>
              <div data-categoryid="32069" data-articleid="25880"
                   data-categoryname="Mouse models"
                   class="flagImage" title="Flag 'Mouse models' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Reperfusion%22" title="Search for articles in the subject area:'Reperfusion'"><div class="flagText">Reperfusion</div></a>
              <div data-categoryid="24659" data-articleid="25880"
                   data-categoryname="Reperfusion"
                   class="flagImage" title="Flag 'Reperfusion' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Transgenic+animals%22" title="Search for articles in the subject area:'Transgenic animals'"><div class="flagText">Transgenic animals</div></a>
              <div data-categoryid="33751" data-articleid="25880"
                   data-categoryname="Transgenic animals"
                   class="flagImage" title="Flag 'Transgenic animals' as inappropriate"></div>
          </li>
    </ul>
</div>

<div class="ad">
    <div class="title">Advertisement</div>






  <iframe id='a0852f54' name='a0852f54'
    src='http://ads.plos.org/www/delivery/afr.php?zoneid=381&amp;cb=3832'
    frameborder='0' scrolling='no' width='160' height='600'>
    <a href='http://ads.plos.org/www/delivery/ck.php?n=a0852f54&amp;cb=4418'
      target='_top'><img src='http://ads.plos.org/www/delivery/avw.php?zoneid=381&amp;cb=8206&amp;n=a0852f54'
      border='0' alt=''/>
    </a>
  </iframe>



</div>

<div id="twitter-alm-timeline" class="twitter-alm-timeline"></div>


</div><!-- sidebar -->
    </div>
  </div>
</div>
<script src="http://wl.figshare.com/static/p_widget.js" type="text/javascript"></script><div id="pageftr">
  <div class="ftr-cols cf">
    <div class="col col-1">
      <img src="/images/logo-plos-footer.png" alt="PLOS Logo" class="logo" />
      <p><a href="/static/releaseNotes">Ambra 2.9.16</a> Managed Colocation provided <br />by <a href="http://www.isc.org/">Internet Systems Consortium</a>.<p>
      <div class="nav nav-aux">
        <a href="/static/privacy">Privacy Policy</a> |
        <a href="/static/terms">Terms of Use</a> |
        <a href="http://www.plos.org/advertise/">Advertise</a> |
        <a href="http://www.plos.org/about/media-inquiries/">Media Inquiries</a>
      </div>
    </div>
    <div class="col col-2">
      <p><a href="http://www.plos.org/publications/journals/">Publications</a></p>
      <div class="nav">
        <ul>
          <li><a href="http://www.plosbiology.org">PLOS Biology</a></li>
          <li><a href="http://www.plosmedicine.org">PLOS Medicine</a></li>
          <li><a href="http://www.ploscompbiol.org">PLOS Computational Biology</a></li>
          <li><a href="http://currents.plos.org">PLOS Currents</a></li>
          <li><a href="http://www.plosgenetics.org">PLOS Genetics</a></li>
          <li><a href="http://www.plospathogens.org">PLOS Pathogens</a></li>
          <li><a href="http://www.plosone.org">PLOS ONE</a></li>
          <li><a href="http://www.plosntds.org">PLOS Neglected Tropical Diseases</a></li>
        </ul>
      </div>
    </div>
    <div class="col col-3">
      <div class="nav">
        <p><a href="http://www.plos.org">plos.org</a></p>
        <p><a href="http://blogs.plos.org">Blogs</a></p>
        <p><a href="http://www.ploscollections.org">Collections</a></p>
        <p><a href="/feedback/new">Send us feedback</a></p>

        <p>California (US) corporation #C2354500, based in San Francisco</p>
      </div>
    </div>
  </div>
</div><!-- pageftr -->

</div><!-- end page-wrap, this div is in header.ftl -->
<script type="text/javascript" src="/javascript/jquery-1.8.1-min.js?v=Tm7VCOzZz3lE03ghpkS6SWkHbyI"></script>
<script type="text/javascript" src="/javascript/ga-min.js?v=lNQ4gt8QcPDatjsdOFl_FGpPhLY"></script>
<script type="text/javascript" src="/javascript/jquery.hoverIntent-min.js?v=mRiGNYY9cIXxVb8u0K_MdW7hHnc"></script>
<script type="text/javascript" src="/javascript/jquery.placeholder-min.js?v=21Pn56Ur9h1N4K4VZDa0nqI3Pxo"></script>
<script type="text/javascript" src="/javascript/jquery.jsonp-2.4.0-min.js?v=lqTpzoHfSq3I5Ygo01qq5WankEo"></script>
<script type="text/javascript" src="/javascript/jquery-ui-1.9.2.custom-min.js?v=raSSlfNO0YsV5uUpAKmTB9n5VTc"></script>
<script type="text/javascript" src="/javascript/jquery.tooltip-min.js?v=cw+6Smh+mdryIA25xvqIvHMrnZM"></script>
<script type="text/javascript" src="/javascript/jquery.uniform-min.js?v=kYUAnX6W2W_2fK3RIuQ2m_YFG9U"></script>
<script type="text/javascript" src="/javascript/jquery.pjax-min.js?v=939kLBjL5_YKbx71T1RHjYaD4l8"></script>
<script type="text/javascript" src="/javascript/imagesloaded-min.js?v=XeuAp8Gc3mvQUo+wZCSF8ttPwvw"></script>
<script type="text/javascript" src="/javascript/figviewer-min.js?v=yPUa0sUQ_iHkI+IRv2i9bjyZJFo"></script>
<script type="text/javascript" src="/javascript/global-min.js?v=0Q3PwjeaWtXYDnqIsQvnL_ou0qs"></script>
<script type="text/javascript" src="/javascript/jquery.touchswipe-min.js?v=huaek_e6HqTduvCNAN91dJolTyw"></script>
<script type="text/javascript" src="/javascript/jquery.base64-min.js?v=VwV1zeVqKZj5FCAdlK0q5NRxbBg"></script>
<script type="text/javascript" src="/javascript/alm-min.js?v=Y5gm6B0b4Kx2YHNObNrgEeBgXlY"></script>
<script type="text/javascript" src="/javascript/taxonomy-browser-min.js?v=vBVMuDMYkGJCXIUxLe35GoyiJNw"></script>
<script type="text/javascript" src="/javascript/jquery.filterize-min.js?v=j0ZKVnHyk2nhFy8eIuNJkp7xaM0"></script>
<script type="text/javascript" src="/javascript/plosone-min.js?v=TK4H4arL_XBSwwJq+K1N3kqYfAI"></script>
<script type="text/javascript" src="/javascript/twitter-min.js?v=xKgcxLsQFXy+at1ao1NVke8nFlM"></script>
<script type="text/javascript" src="/javascript/crossmark.1.4-min.js?v=3FO4k0SjwTaGNnKGNSqthar1080"></script>
<script type="text/javascript">
  var _sf_async_config={uid:16579,domain:"plosone.org"};
  (function(){
    function loadChartbeat() {
      window._sf_endpt=(new Date()).getTime();
      var e = document.createElement('script');
      e.setAttribute('language', 'javascript');
      e.setAttribute('type', 'text/javascript');
      e.setAttribute('src',
          (("https:" == document.location.protocol) ? "https://a248.e.akamai.net/chartbeat.download.akamai.com/102508/" : "http://static.chartbeat.com/") +
              "js/chartbeat.js");
      document.body.appendChild(e);
    }
    var oldonload = window.onload;
    window.onload = (typeof window.onload != 'function') ?
        loadChartbeat : function() { oldonload(); loadChartbeat(); };
  })();
</script>
<!-- <script type="application/javascript" src="http://crossmark.crossref.org/javascripts/v1.3/crossmark.min.js"></script> -->

</body>
</html>
